<SEC-DOCUMENT>0001628280-20-000294.txt : 20200110
<SEC-HEADER>0001628280-20-000294.hdr.sgml : 20200110
<ACCEPTANCE-DATETIME>20200110172929
ACCESSION NUMBER:		0001628280-20-000294
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200110
ITEM INFORMATION:		Other Events
FILED AS OF DATE:		20200110
DATE AS OF CHANGE:		20200110

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CUMBERLAND PHARMACEUTICALS INC
		CENTRAL INDEX KEY:			0001087294
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33637
		FILM NUMBER:		20522053

	BUSINESS ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE,
		STATE:			TN
		ZIP:			37203
		BUSINESS PHONE:		615-255-0068

	MAIL ADDRESS:	
		STREET 1:		2525 WEST END AVENUE
		STREET 2:		SUITE 950
		CITY:			NASHVILLE
		STATE:			TN
		ZIP:			37203
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a8-kcaldolorrtulaunch.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Document</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s3f412f60eff44382a5ec8de8740bd33d"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">UNITED STATES</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;">WASHINGTON, D.C. 20549</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">________________________________</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;">FORM 8-K</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">________________________________</font></div><div style="line-height:120%;padding-top:16px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">PURSUANT TO SECTION 13 OR 15(D)</font></div><div style="line-height:120%;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-weight:bold;">OF THE SECURITIES EXCHANGE ACT OF 1934</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.5546875%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:52%;"></td><td style="width:48%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date of Report (Date of Earliest Event Reported):  January 10, 2020 (January 7, 2020)</font></div></td></tr></table></div></div><div style="line-height:120%;"><hr></div><div style="line-height:120%;text-align:center;font-size:16pt;"><font style="font-family:inherit;font-size:16pt;font-weight:bold;">CUMBERLAND PHARMACEUTICALS INC.</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(Exact name of registrant as specified in its charter)     </font><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.046875%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:0%;"></td><td style="width:39%;"></td><td style="width:28%;"></td><td style="width:33%;"></td></tr><tr><td><font>&#160;</font></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">Tennessee</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">001-33637</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">62-1765329</font></div></td></tr><tr><td><font>&#160;</font></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(State or other jurisdiction of incorporation)</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Commission File Number)</font></div></td><td rowspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(I.R.S. Employer Identification No.)</font></div></td></tr><tr><td><font>&#160;</font></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-top:16px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">2525 West End Avenue, Suite 950, Nashville, Tennessee 37203</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="3" style="vertical-align:middle;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Address of principal executive offices) (Zip Code)</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(615) 255-0068</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Registrant&#8217;s telephone number, including area code)</font></div></td></tr><tr><td><font>&#160;</font></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Not Applicable</font></div></td></tr><tr><td><font>&#160;</font></td><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">(Former name or former address, if changed since last report)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">____________________________________________&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</font></div><div style="line-height:120%;text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:4%;"></td><td style="width:4%;"></td><td style="width:92%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:4%;"></td><td style="width:4%;"></td><td style="width:92%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:4%;"></td><td style="width:4%;"></td><td style="width:92%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:6pt;"><font style="font-family:inherit;font-size:6pt;">&#160;</font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:98.4375%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:4%;"></td><td style="width:4%;"></td><td style="width:92%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Securities registered pursuant to Section 12(b) of the Act:</font></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:93.5546875%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:34%;"></td><td style="width:1%;"></td><td style="width:18%;"></td><td style="width:1%;"></td><td style="width:46%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Class</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Times_New_Roman;font-size:10pt;">Trading Symbol</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Times_New_Roman;font-size:10pt;">Name of exchanged on which registered</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;border-top:1px solid #000000;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Common stock, no par value</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Times_New_Roman;font-size:10pt;">CPIX</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:center;font-size:10pt;"><font style="font-family:Times_New_Roman;font-size:10pt;">NASDAQ Global Select Market</font></div></td></tr></table></div></div><div style="line-height:120%;padding-bottom:8px;padding-top:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#160;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#160;240.12b-2 of this chapter).</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Emerging growth company </font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div style="line-height:120%;padding-bottom:8px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </font><font style="font-family:Wingdings;font-size:10pt;">o</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="sff4af0f9921c45b8b75c21f54debb46a"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Item 8.01 Other Events</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On January 7, 2020, Cumberland announced the launch of Caldolor</font><font style="font-family:inherit;font-size:10pt;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:10pt;">&#32;(</font><font style="font-family:inherit;font-size:10pt;font-style:italic;">ibuprofen</font><font style="font-family:inherit;font-size:10pt;">) Injection in a </font><font style="font-family:inherit;font-size:10pt;font-style:italic;font-weight:bold;">ready-to-use bag</font><font style="font-family:inherit;font-size:10pt;">&#32;that may be administered without dilution for pain relief. This launch follows FDA approval in 2019 of the product&#8217;s new delivery method. </font></div><div style="line-height:120%;padding-bottom:10px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A non-steroidal anti-inflammatory drug (NSAID), Caldolor may be used as the sole method of treatment for mild-moderate pain or as part of a multi-modal treatment for severe pain. Thus it is positioned to play an important role in combatting the nation&#8217;s opioid crisis, which claims the lives of over 130 Americans a day, according to </font><font style="font-family:inherit;font-size:10pt;font-style:italic;">The Centers for Disease Control and Prevention</font><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The new formulation of Caldolor comes in a pre-mixed bag containing 800 mg of ibuprofen in a 200 mL patented low sodium formulation for injection that is ready to use. It is the first and only FDA-approved pre-mixed bag of ibuprofen. Caldolor is still available as an 800 mg/8mL single-dose vial (100mg/mL) for dilution in addition to the ready-to-use bag (4 mg/mL). The new, premixed presentation provides healthcare professionals a formulation that is easy to administer,  helping manage the treatment of patient pain and fever, while reducing opioid consumption. </font></div><div style="line-height:120%;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">A copy of the press release is furnished as </font><a style="font-family:inherit;font-size:10pt;" href="finalcaldolorrtulaunch.htm"><font style="font-family:inherit;font-size:10pt;">Exhibit 99.1</font></a><font style="font-family:inherit;font-size:10pt;">.</font></div><div style="line-height:120%;padding-bottom:10px;text-align:justify;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><hr style="page-break-after:always"><div><a name="s92146a1c279e4610aaf3fef8d2ffbb0d"></a></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div><div><br></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURES</font></div><div style="line-height:120%;padding-top:15px;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="7"></td></tr><tr><td style="width:24%;"></td><td style="width:13%;"></td><td style="width:12%;"></td><td style="width:13%;"></td><td style="width:12%;"></td><td style="width:13%;"></td><td style="width:13%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td colspan="3" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Cumberland Pharmaceuticals Inc.</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Dated: January 10, 2020</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By:</font></div></td><td colspan="2" style="vertical-align:top;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">/s/ Michael Bonner</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Michael Bonner</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Chief Financial Officer</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;padding-top:15px;text-align:left;"><hr></div><div style="line-height:120%;padding-top:15px;text-align:left;text-indent:288px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Exhibit&#160;Index </font></div><div style="line-height:120%;padding-top:15px;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:76.5625%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:20%;"></td><td style="width:13%;"></td><td style="width:67%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Exhibit No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;border-bottom:1px solid #000000;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;font-weight:bold;">Description</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:7pt;"><font style="font-family:inherit;font-size:7pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;font-size:10pt;"><a style="font-family:inherit;font-size:10pt;" href="finalcaldolorrtulaunch.htm"><font style="font-family:inherit;font-size:10pt;">Press release dated January 7, 2020</font></a></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:9px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div><div><br></div><div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>finalcaldolorrtulaunch.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2020 Workiva -->
		<title>Exhibit</title>
	</head>
	<body><div style="font-family:Times New Roman;font-size:10pt;">
<div><a name="sA7A64E2FCCC253BE05E485BFB39F7F4F"></a></div><div><div style="line-height:120%;padding-top:8px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><div><br></div><div style="line-height:144%;padding-bottom:32px;padding-top:8px;text-align:center;"><img src="finalcaldolorrtulaunc_image1.jpg" alt="finalcaldolorrtulaunc_image1.jpg" style="height:94px;width:413px;"></div><div style="line-height:120%;padding-bottom:13px;padding-top:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">CUMBERLAND PHARMACEUTICALS ANNOUNCES </font></div><div style="line-height:120%;padding-bottom:13px;padding-top:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">THE NATIONAL LAUNCH OF A NEW CALDOLOR </font></div><div style="line-height:120%;padding-bottom:13px;padding-top:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">&#32;READY-TO-USE PRODUCT</font></div><div style="line-height:120%;padding-bottom:13px;padding-top:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Caldolor</font><font style="font-family:inherit;font-size:11pt;font-style:italic;"><sup style="vertical-align:top;line-height:120%;font-size:7pt">&#174;</sup></font><font style="font-family:inherit;font-size:11pt;font-style:italic;">&#32;now available in a pre-mixed, ready-to-use bag. </font></div><div style="line-height:144%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;font-style:italic;">Product designed to help address national opioid crisis.</font></div><div style="line-height:144%;padding-bottom:8px;padding-top:8px;text-align:center;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">NASHVILLE, Tenn. (Tuesday, January 7, 2020)</font><font style="font-family:inherit;font-size:12pt;">&#32;&#8211; Cumberland Pharmaceuticals Inc. </font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">(NASDAQ: CPIX),</font><font style="font-family:inherit;font-size:12pt;">&#32;a specialty pharmaceutical company with a focus on hospital acute care, today announced the launch of Caldolor</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">ibuprofen</font><font style="font-family:inherit;font-size:12pt;">) Injection in a </font><font style="font-family:inherit;font-size:12pt;font-style:italic;font-weight:bold;">ready-to-use bag</font><font style="font-family:inherit;font-size:12pt;">&#32;that may be administered without dilution for pain relief. This launch follows FDA approval in 2019 of the product&#8217;s new delivery method. </font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">A non-steroidal anti-inflammatory drug (NSAID), Caldolor may be used as the sole method of treatment for mild-moderate pain or as part of a multi-modal treatment for severe pain. Thus it is positioned to play an important role in combatting the nation&#8217;s opioid crisis, which claims the lives of over 130 Americans a day, according to </font><font style="font-family:inherit;font-size:12pt;font-style:italic;">The Centers for Disease Control and Prevention</font><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Even short-term opioid use after surgery can lead to long-term addiction. Prompt and appropriate pain management is vital to mitigating opioid use. Published data for Caldolor supports administration just prior to surgery and throughout the postoperative period. As a result patients experience significantly less pain upon awakening, then  remain in significantly less pain, while also reducing their opioid consumption. </font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">&#8220;We have been encouraged by the significant number of physicians who have incorporated Caldolor into their pain management regimens as a way to combat the negative effects of opioid use,&#8221; said A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals. &#8220;The new ready-to-use presentation of Caldolor offers hospitals and other medical facilities a proven product that is now easier to administer and, thus, has the potential  to further reduce opioid use.&#8221;</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Caldolor possesses three key therapeutic properties: anti-inflammatory, analgesic and antipyretic action. Uncontrolled inflammation may contribute to hypersensitivity to pain and lead to chronic post-operative pain. Pre-empting this response with Caldolor may reduce the need for continued post-operative opioids and improve recovery through reduction in opioid-related side effects, such as nausea, vomiting and constipation.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;padding-bottom:12px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The new formulation of Caldolor comes in a pre-mixed bag containing 800 mg of ibuprofen in a 200 mL patented low sodium formulation for injection that is ready to use. It is the first and only FDA-approved pre-mixed bag of ibuprofen. Caldolor is still available as an 800 mg/8mL single&#8211;dose vial (100mg/mL) for dilution in addition to the ready-to-use bag (4 mg/mL). The new, premixed presentation provides healthcare professionals a formulation that is easy to administer,  helping manage the treatment of patient pain and fever, while reducing opioid consumption. </font></div><div style="line-height:144%;padding-bottom:12px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Prudent and careful management of pain is among the most important responsibilities of every healthcare provider. New strategies are emerging to control acute and chronic pain in the hospital setting, and Cumberland has provided grants in support of educational webinars in partnership with two of the nation&#8217;s leading physician services companies. Through these initiatives, three webinars have been developed that introduce healthcare providers to new therapies and pain modalities for more effective pain management. These accredited webinars recognize that many patients are first introduced to opioids in a hospital or surgery center setting and, in some cases, may become dependent upon or even abuse their opioid treatments. This cycle can be avoided through the introduction of non-opioid medications like Caldolor which can serve as the basis for multimodal strategies to improve pain management. </font></div><div style="line-height:144%;padding-bottom:12px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">There is a growing body of published evidence showing that Caldolor can significantly decrease both surgical pain and opioid use. One clinical study, conducted at The Ohio State Wexner Medical Center, assessed the efficacy of Caldolor compared to ketorolac for the treatment of postoperative pain in patients undergoing arthroscopic knee surgery, and it revealed more effective pain control and opioid-sparing activity with Caldolor when compared to ketorolac. The results of this study demonstrated that the use of IV ibuprofen, compared to IV ketorolac, significantly lowered postoperative pain scores and opioid consumption in patients undergoing arthroscopic knee surgeries. </font></div><div style="line-height:144%;padding-bottom:12px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Another study, conducted at Tufts University School of Dental Medicine in Boston, compared the preemptive analgesic effects of Caldolor to IV acetaminophen in controlling post-surgical pain and reliance on opioids for rescue pain control. The study investigators concluded that preemptive anesthesia with Caldolor IV ibuprofen is superior when compared to IV acetaminophen in reducing post-surgical pain and opioid use. </font></div><div style="line-height:144%;padding-bottom:12px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cumberland has recently completed a clinical study for the use of Caldolor in patients from birth to 6 months of age. This comes after the Company conducted clinical trials and received FDA approval which extended the approved adult use to use in children aged 6 months to 17 years old. Topline results from the newborn study are forthcoming and will add to the growing body of literature that supports the safety and efficacy of the product.</font></div><div style="line-height:144%;padding-bottom:12px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">About Caldolor </font></div><div style="line-height:144%;padding-bottom:12px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Caldolor can be a key component in cost effective Enhanced Recovery After Surgery (ERAS) multimodal treatment protocols. Clinical studies of Caldolor demonstrate:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:13px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:12pt;padding-left:12px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Up to a 58% reduction in opioid use compared to placebo group</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">1</sup>&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:12pt;padding-left:12px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Up to a 43% reduction in VAS scores at rest compared to opioids alone</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">2</sup>&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:12pt;padding-left:12px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Patients reporting significantly less pain shortly after waking</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">3</sup>&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:12pt;padding-left:12px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Patients remain in significantly less pain during recovery</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">3</sup>&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:12pt;padding-left:12px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Potential to improve quality of recovery and reduce postsurgical fatigue</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">4</sup>&#160;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-top:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:36px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:144%;font-size:12pt;padding-left:12px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Significant pain and fever reduction in children ages six months and older</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">5</sup>&#160;</font></div></td></tr></table><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Caldolor is indicated in adults and pediatric patients six months and older for the management of mild to moderate pain and the management of moderate to severe pain as an adjunct to opioid analgesics, as well as the reduction of fever. It should be noted that Caldolor</font><font style="font-family:inherit;font-size:12pt;"><sup style="vertical-align:top;line-height:120%;font-size:8pt"> </sup></font><font style="font-family:inherit;font-size:12pt;">is contraindicated in patients with known hypersensitivity to ibuprofen or other NSAIDs, patients with a history of asthma or other allergic-type reactions after taking aspirin or other NSAIDs. Caldolor is contraindicated for use during the peri-operative period in the setting of coronary artery bypass graft (CABG) surgery. Caldolor should be used with caution in patients with prior history of ulcer disease or GI bleeding, in patients with fluid retention or heart failure, in the elderly, those with renal impairment, heart failure, liver impairment, and those taking diuretics or ACE inhibitors. Blood pressure should be monitored during treatment with Caldolor. For full prescribing information, including boxed warning, visit </font><a style="font-family:inherit;font-size:11pt;color:#0000ff;text-decoration:underline;" href="#"><font style="font-family:inherit;font-size:11pt;color:#0000ff;text-decoration:underline;">www.caldolor.com</font></a><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:9.5pt;"><font style="font-family:inherit;font-size:9.5pt;font-weight:bold;">References:</font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">1.)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Shephard DM, Jahnke H, White WL, et al. Randomized, double-blinded, placebo-controlled trial comparing two multimodal opioid-minimizing pain management regimens following transsphenoidal surgery. </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">J Neurosurg</font><font style="font-family:inherit;font-size:9pt;">&#32;2018; 128(2): 444-451.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">2.)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Moss. JR, Watcha MF, Bendel LP, et al. A multicentre, randomized, double-blind placebo-controlled, single dose trial of the safety and efficacy of intravenous ibuprofen for treatment of pain in pediatric patients undergoing tonsillectomy. </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Pediatric Anesthesia</font><font style="font-family:inherit;font-size:9pt;">&#32;2014; 24(5): 483-498. </font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">3.)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Singla N, Rock A, and Pavliv L. A multi-center, randomized, double-blind placebo-controlled trial of intravenous-ibuprofen (IV-ibuprofen) for treatment of pain in post-operative orthopaedic adult patients. </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Pain Med</font><font style="font-family:inherit;font-size:9pt;">&#32;2010; 11(8): 1284-1293.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">4.)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">Le V, Kurnutala L, Schianodicola J, et al. Premedication with intravenous ibuprofen improves recovery characteristics and stress response in adults undergoing laparoscopic cholecystectomy:  a randomized controlled trial. </font><font style="font-family:inherit;font-size:9pt;font-style:italic;">Pain Med</font><font style="font-family:inherit;font-size:9pt;">&#32;2016; 17(6): 1163-1173.</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:48px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:130%;font-size:9pt;padding-left:24px;"><font style="font-family:inherit;font-size:9pt;">5.)</font></div></td><td style="vertical-align:top;"><div style="line-height:130%;text-align:justify;font-size:9pt;"><font style="font-family:inherit;font-size:9pt;">CALDOLOR [Package Insert] Nashville, TN: Cumberland Pharmaceuticals Inc. 2019. </font></div></td></tr></table><div style="line-height:144%;padding-bottom:12px;padding-top:16px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;text-decoration:underline;">About Cumberland Pharmaceuticals</font></div><div style="line-height:144%;padding-bottom:9px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the delivery of high quality prescription brands to improve patient care. The Company develops, acquires and commercializes brands for the hospital acute care and gastroenterology market segments. These medical specialties are categorized by moderately concentrated prescriber bases that we believe can be penetrated effectively by targeted sales forces. The Company&#8217;s portfolio of FDA approved brands includes:</font></div><table cellpadding="0" cellspacing="0" style="padding-top:10px;padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:29px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:5px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Acetadote</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">acetylcysteine</font><font style="font-family:inherit;font-size:12pt;">) Injection, for the treatment of acetaminophen poisoning;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:6px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Caldolor</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">ibuprofen</font><font style="font-family:inherit;font-size:12pt;">) Injection, for the treatment of pain and fever;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:6px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Kristalose</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">lactulose</font><font style="font-family:inherit;font-size:12pt;">) for Oral Solution, a prescription laxative, for the treatment of chronic and acute constipation;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:6px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Omeclamox</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;font-weight:bold;">-Pak</font><font style="font-family:inherit;font-size:12pt;">, (</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">omeprazole, clarithromycin, amoxicillin</font><font style="font-family:inherit;font-size:12pt;">) for the treatment of Helicobacter pylori (</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">H. pylori</font><font style="font-family:inherit;font-size:12pt;">) infection and related duodenal ulcer disease;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:6px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">RediTrex</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">TM</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">methotrexate</font><font style="font-family:inherit;font-size:12pt;">) Injection, for the treatment of adult and pediatric patients with rheumatoid arthritis and adults with psoriasis;</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:6px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Vaprisol</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">conivaptan</font><font style="font-family:inherit;font-size:12pt;">) Injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia; and</font></div></td></tr></table><table cellpadding="0" cellspacing="0" style="padding-bottom:8px;font-family:Times New Roman; font-size:10pt;"><tr><td style="width:30px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:12pt;padding-left:6px;"><font style="font-family:inherit;font-size:12pt;">&#8226;</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Vibativ</font><font style="font-family:inherit;font-size:12pt;font-weight:bold;"><sup style="vertical-align:top;line-height:120%;font-size:8pt">&#174;</sup></font><font style="font-family:inherit;font-size:12pt;">&#32;(</font><font style="font-family:inherit;font-size:12pt;font-style:italic;">telavancin</font><font style="font-family:inherit;font-size:12pt;">) Injection, for the treatment of certain serious bacterial infections including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections.</font></div></td></tr></table><div style="line-height:144%;padding-bottom:9px;padding-top:24px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;padding-bottom:9px;padding-top:24px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">For more information on Cumberland&#8217;s approved products, including full prescribing information, please visit the individual product websites, links to which can be found on the Company&#8217;s website </font><a style="font-family:inherit;font-size:11pt;color:#0000ff;text-decoration:underline;" href="#"><font style="font-family:inherit;font-size:11pt;color:#0000ff;text-decoration:underline;">www.cumberlandpharma.com</font></a><font style="font-family:inherit;font-size:12pt;">.</font></div><div style="line-height:144%;padding-bottom:9px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">The Company has Phase II clinical programs underway evaluating its ifetroban product candidates in patients with cardiomyopathy associated with Duchenne Muscular Dystrophy (&#8220;DMD&#8221;), Systemic Sclerosis (&#8220;SSc&#8221;), and Aspirin-Exacerbated Respiratory Disease ("AERD"), Hepatorenal Syndrome (&#8220;HRS&#8221;) and Portal Hypertension (&#8220;PH&#8221;).</font></div><div style="line-height:144%;padding-bottom:9px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;padding-bottom:9px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Forward-Looking Statements</font></div><div style="line-height:144%;padding-bottom:9px;padding-top:8px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">This press release contains forward-looking statements, which are subject to certain risks and reflect Cumberland's current views on future events based on what it believes are reasonable assumptions. No assurance can be given that these events will occur. Forward-looking statements include, among other things, statements regarding our intent, belief or expectations. As with any business, all phases of Cumberland's operations are subject to factors outside of its control, and any one or combination of these factors could materially affect Cumberland's results of operations. These factors include market conditions, competition, an inability of manufacturers to produce Cumberland's products on a timely basis or failure of manufacturers to comply with regulations applicable to pharmaceutical manufacturers, maintaining an effective sales and marketing infrastructure and other factors discussed in the Company's most recent Form 10-K and subsequent 10-Q's as filed with the SEC. There can be no assurance that results anticipated by the Company will be realized or that they will have the expected effects. Readers are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date hereof. The Company does not undertake any obligation to publicly revise these statements to reflect events after the date hereof.</font></div><div style="line-height:144%;padding-bottom:9px;padding-top:8px;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">###</font></div><div style="line-height:120%;padding-bottom:9px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;padding-bottom:9px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;margin-left:auto;margin-right:auto;width:89.16349809885932%;border-collapse:collapse;text-align:left;"><tr><td colspan="3"></td></tr><tr><td style="width:48%;"></td><td style="width:3%;"></td><td style="width:49%;"></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:justify;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Investor Contact:</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:justify;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Media Contact:</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:justify;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Erin Gull</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:justify;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Jeff Bradford</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:justify;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Corporate Relations</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:justify;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">the Bradford Group</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:20px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr></table></div></div><div style="line-height:144%;padding-top:14px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;padding-top:10px;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;">SOURCE: Cumberland Pharmaceuticals Inc.</font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:144%;text-align:justify;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div><div style="line-height:120%;padding-bottom:32px;padding-top:8px;text-align:justify;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div>	</div></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>finalcaldolorrtulaunc_image1.jpg
<TEXT>
begin 644 finalcaldolorrtulaunc_image1.jpg
M_]C_X  02D9)1@ ! @$!+ $L  #_X0R]17AI9@  24DJ  @    .   ! P !
M    <@8   $! P !    =P$   (! P $    M@    ,! P !     0    8!
M P !    !0   !(! P !     0   !4! P !    !    !H!!0 !    O@
M !L!!0 !    Q@   !P! P !     0   "@! P !     @   #$! @ <
MS@   #(! @ 4    Z@   &F'!  !      $  "P!   (  @ "  ( ,#&+0 0
M)P  P,8M ! G  !!9&]B92!0:&]T;W-H;W @0U,S(%=I;F1O=W, ,C Q-3HP
M,SHQ,B Q,3HT-3HT-0    ,  : #  $   #__P   J $  $   !R!@   Z $
M  $   !W 0          !@ # 0,  0    8    : 04  0   'H!   ; 04
M 0   ((!   H 0,  0    (    ! @0  0   (H!   " @0  0   "L+
M    2     $   !(     0   /_8_^  $$I&248  0(  $@ 2   _^T #$%D
M;V)E7T--  +_[@ .061O8F4 9(     !_]L A  ," @("0@,"0D,$0L*"Q$5
M#PP,#Q48$Q,5$Q,8$0P,# P,#!$,# P,# P,# P,# P,# P,# P,# P,# P,
M# P, 0T+"PT.#1 .#A 4#@X.%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1"  D * # 2(  A$! Q$!_]T
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M0DE-!"\      $H* 0$ 2    $@              - "  !  @
M   8 P  9 (    !P ,  + $   !  \G 0!L;'5N             #A"24T#
M[0      $ $L     0 ! 2P    !  $X0DE-!"8       X
M/X   #A"24T$#0      !    '@X0DE-!!D       0    >.$))30/S
M   )           ! #A"24T$"@       0  .$))32<0       *  $
M     CA"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H
M!@       0 R     0!:    !@       0 U     0 M    !@       3A"
M24T#^       <   _____________________________P/H     /______
M______________________\#Z     #_____________________________
M ^@     _____________________________P/H   X0DE-! @      !
M   !   "0    D      .$))300>       $     #A"24T$&@     #7P
M  8              7<   9R    %0!? $@ ;P!R &D >@!O &X = !A &P
M( !C &\ ; !O '( ( !T &D 9@    $                          0
M           &<@   7<                      0
M       0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M  !"=&]M;&]N9P   7<     4F=H=&QO;F<   9R    !G-L:6-E<U9L3',
M   !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M    !V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R
M:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y
M<&4     26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $
M %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   %W
M     %)G:'1L;VYG   &<@    -U<FQ415A4     0       &YU;&Q415A4
M     0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !
M   .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !
M   ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L
M=     EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A
M=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90
M  !.;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M          QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO
M;F<      #A"24T$*       #     $_\        #A"24T$%       !
M  ,X0DE-! P     "T<    !    H    "0   '@  !#@   "RL &  !_]C_
MX  02D9)1@ ! @  2 !(  #_[0 ,061O8F5?0TT  O_N  Y!9&]B90!D@
M  '_VP"$  P(" @)" P)"0P1"PH+$14/# P/%1@3$Q43$Q@1# P,# P,$0P,
M# P,# P,# P,# P,# P,# P,# P,# P,# P!#0L+#0X-$ X.$!0.#@X4% X.
M#@X4$0P,# P,$1$,# P,# P1# P,# P,# P,# P,# P,# P,# P,# P,# P,
M#/_  !$( "0 H ,!(@ "$0$#$0'_W0 $  K_Q $_   !!0$! 0$! 0
M   #  $"! 4&!P@)"@L!  $% 0$! 0$!          $  @,$!08'" D*"Q
M 00! P($ @4'!@@% PPS 0 "$0,$(1(Q!4%181,B<8$R!A21H;%"(R054L%B
M,S1R@M%#!R624_#A\6-S-1:BLH,F1)-49$7"HW0V%])5XF7RLX3#TW7C\T8G
ME*2%M)7$U.3TI;7%U>7U5F9VAI:FML;6YO8W1U=G=X>7I[?'U^?W$0 " @$"
M! 0#! 4&!P<&!34!  (1 R$Q$@1!46%Q(A,%,H&1%*&Q0B/!4M'P,R1BX7*"
MDD-3%6-S-/$E!A:BLH,')C7"TD235*,79$55-G1EXO*SA,/3=>/S1I2DA;25
MQ-3D]*6UQ=7E]59F=H:6IK;&UN;V)S='5V=WAY>GM\?_V@ , P$  A$#$0 _
M /4WO:QI>\AK6B7.)@ #N2LGK'UCHZ;C>LVE^02)8!#&GXN?[F_]MJ74NFYO
M4\ZNNRWT.F8X#RUL%]UI)^E,M93CM#=GM_26O_X&I&R>A=-S*VU9=9O:T0 Y
MSAI_ULL3APBKU[@*8?5K/R.I="P^H9.WULJOU7AHAHW$G8W^2SZ"TUQ-UOU@
MZ1:_$Z53<WI^,XLQJ10;:Q6WZ+0\,]9S?^O+;Z!]8G=1:*<RK[/ECEHD-=_8
ML_25._D/_P"W$)$$DC:U.VDN=^L>7U8]9Z1TCIN9]@&>,I]MXJ9:[]794^MC
M6WS7M=ZOO1L+%^LN!;E.SNHU]1P_L^ZE[JFU7,O:7;AZ=#&TNQW5[/IO]3U$
M>#0&QKTZ_NJMW$ESU?5<\_4#]L&W_*'[*=E>MM;_ #PH-WJ>GM]+^<]VS9Z:
MJ]6Z_P!7P;.BY%(&119B79?4\<!H?976,/U+<:1_/8WVFW)]!O\ 2&,]'^<]
M)(0)TTZC[%/5I+EKOK/D9GUAZ;1TFRNSI!O-&7DM(>+K;,:[-JHH=!_1XU5=
M5N1:Q_\ .7TT_P"F5',ZOUFWKG4\:OJ69BT8E]==56)TW[8T-=33<XOOKHNV
MO]2Q_L>B,9ZD#2T6]NDN)N^L'6_^9V#G#*<W,R,YN*_)90U]IJ.19C;OL#6V
M-^U^BQN[%8SU?6_0_P ZM7ZO5]9NM^UY/5LG*QF%U;L7*P&X;BZ&N;8-]=-^
MQN[_ (MZ1QT"21U'7HJWH4EY=C_6[JUW2#E'ZPO;U9S;74],;@->'OK<\5T5
MVLH_2>HUK-[V/_1;UW!ZAF_\Y\/ +MN/=T^[(MJVC^=99C5M=O\ YSV-ML]N
MY&6(QWKKW_14#;LI(.9EX^#B79F2[T\?&8ZVU_,-8-[S ^EPN=^KG7NHVYXQ
M.L65[^IU'-Z>QFS]$T']/TJTM+7VY&)2_&O]3TOTGJY/^@3!$D$]DO4)+E7?
M6;.Z?UKJ1ZB _H=&37C#(8WW8KG48UX?D[1[L*^R_P#G_P#M/;_._H?3V$;U
MGJ/[)^M&4;0;>F79+<)VUL-97C4Y-&D?I/TEF_\ 2)W ?R_YRK>F27&[OK=B
M_5]OUA'66Y8JQ!FVX-^+4QCV"O[1;2+\;9=6_;N])ZW^GW]2RLLY;G-_9>12
MRS&80!8"]K'^_G]ZSU/^MH&%=0:1;__0]&ZG9G8K?M6&SU@!^EH()D#\]FWW
M;EB8_P!?,>PD68=@(,36]CQ_T_175*AE]"Z1F6&W(Q:W6GFQHV//]:RK8]R2
MFQA93,S$IRF-+&7L#VM=&X!PGW;2YJCU!^%3C/R<US:ZJ1N]5W+3/M+#]+?N
M^AM^FN(Z7U7K[^M9W3,:VU_3\#)?CTUUU-(KK8=M=;\@5E_T/]-=ZBZ@]$^U
M]1JS<USG5XSA9CT.<7?I!]&U\ES6^F[WUL8GF'"?4>EZ(!MC]8.E]/R[,/-R
MLZ[IE^(;&X^12]C'?I63D5_IZ[ZW?HJ/4^A^C]+U%'IW0,##SGYMV??U#+S<
M<8U=F596YQH:77NKH&/7C[F[K-[W?I%IYO3\?.]$9 +FT/-@9^:XNKMQG,M'
MYU?IY#_:HY/2\/*?CNM9+<4.%=0@,A[?2U;'YK/H;4A+0"REY]_U3P*^C&E_
M7\]G1_L_IZWXXH^SENS;ZKL7^9]$_3]3Z"VLC Z=CY.%GV6&G]GUOQ<=NX;"
M+_09L=N#K++/U>IE/O\ \]2/1\8X>'A%]OV?!]/:T.V[_1;LI^T.KV;]C]E_
ML]/]-76F/1L8].HZ<^RUU&,YAK=OBR*SNI9ZS0VS]&W:SU?Z1_PWK?I4C*]R
M=_P4UST[H%=72[*;*L7$Q,CU<!M3F,I?9D-NI;6S\VSUOM5CJV4_X15S]7L?
M)ZAG9F!UG,QWWW Y=.+906-N9777L<VS'O?79Z+:M];WK0LZ)B6]/Q^GVESZ
M<6-A]K22UCJF.?L8UF]N_P!7]&RO]-^D2Q.CTX>%D8E%]S3DRY]\M]4/=6RB
MS(:\,#?7L=7]H>]S/Z3999_P:7%6Q-J<^OZL=*R>B5=.QLV]U5.4<IN;78Q]
MQR66OMLL?::[*76-RM_J?HOIJ?1L*G[5]HHZ[F=2;6/=3;92^HA\AEGZ#&I<
M[Z#O2L99^8KV+T7"Q:K\>K?]FR6-K?0Y[G- 96,7V/?-S=^.RJM_Z7_!?Z3U
M?4+@85F'6*CDV7UL:UE;; P;6MT&M5=;GO2,M#K?]JG(POJ]T*[H-71L3)MM
MHPWFS'S*[!Z]=CGV6B^C)K8UF]KK+&>UFSTOT=F]$S.BXO5,K&S*>JY-.71C
M;&W8EE(=93<6O]:QIHM9LN?C[V/J975_HUH=+Z8SIM'V>JQUE8@,WAH( GZ3
MJVLW_2_.4.F=(KZ<9;=9=MIKQJ_4V^VJG?Z+/T;6;G?I7;K'I&6I-^7^%\R'
M.HZ-T[J6$[ LZKD]5HKR:[[VW/JLW>F0]F%D!F.QOV9UE;;+:-OJ)\GZN_51
MM6-U#'JQ^G>C;5D8^;A-JI<X_P"#K%M;-M].4RSTO0]_VCU%LXV+7C&XL<YW
MKV&YVX@P7!K=K=![/8J_[(I&'A8M5CV'IVS[+=[2\%E;L7<\.;Z3_4HLMKL_
M1_X3]'Z5GIO2XM=R$L,7&Z777G]0;:VW%ZB[U\EUCFFD-94S%L[-:VGTL?\
M3>K_ ,(JF%]7>A8'1,[ QKG,Z;U4O<7&QI:UN377B-9BVN&WTO3;7]FW^JM'
M(Z=]JQ&8N3?;8T/:^Q[2UCG['>JVMYI:S;5N#?YK9^C_ .N(?[&I'3G=.9=:
M*O4]2MQ<'O9%@R6,8ZUK]U==C?9ZOJ?H_P!&D#XG?\ IQLCZI=-HQ:L?J76,
M^[IS-M0P[KF-JL#6^RA[<:BBZUNQG\WZGYBZ=FPL;LC9 VQQ';:JN7T[[7BL
MHNM)?6X/%VUF[< 6[V^S]%9[O9;3Z=M:L45>C373N=9Z;0S?8=SW;1MW6/\
MSWN_/0E*QJ;*G__1]527RJDDI^HL+[%Z;_L>ST_5M]39_I?4?]IW?\)Z_J;U
M87RJDB=_XJ?JI)?*J2"GZJ27RJDDI^JDE\JI)*?JI)?*J22GZJ27RJDDI^JD
ME\JI)*?JI)?*J22GZJ27RJDDI__9 #A"24T$(0      50    $!    #P!!
M &0 ;P!B &4 ( !0 &@ ;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "
M4 !H &\ = !O ', : !O '  ( !# %, ,P    $ .$))300&       '  8
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M A   '-C;G)#35E+3&%B( ?5  P $P * "P -F%C<W!!4%!,     &YO;F4
M                      #VU@ !     -,M041"10
M                                            !6-P<G0   #
M)&1E<V,   #D    ;G=T<'0   %4    %&)K<'0   %H    %$$R0C    %\
M   LE'1E>'0     *&,I(#(P,#4@061O8F4@4WES=&5M<R!);F,N &1E<V,
M        $U-73U @*$-O871E9"DL(#(P)0
M
M                      !865H@        ]M8  0    #3+5A96B
M                ;69T,@     $ P8   $                    !
M                 0   0 !     ,(!A@)( PP#S@2.!5 &$@;2!Y((5@D8
M"=X*H@MJ## ,]@W #H@/3A 6$-P1I!)J$S(3^!3 %8@64A<<%^88LAE\&D8;
M#AO:'*0=<AX\'P@?U""D(7(B0B,4(^(DM"6$)E8G)"?X*,8IFBIJ*SPL#"S>
M+; N@B]4,"HP_C'2,JHS@C1:-3(V"C;B-[PXE#EN.D8[(#OZ/-(]JCZ$/UQ
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MS#B4.5XZ)#KL.[8\@CU./AH^Y#^R0(!!3$(:0NI#N$2,15Y&+D<"1]A(JDF
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MY1GFX>BCZH_L9>X[\!'QY?.7]4?VY_B'^A/[5_Q#_0G]O?Y?_P/_@?___P"
M (  S "  (  F0"  (  9@"  (  ,P"  (    "  (  ^@!\ )@ R !] )0
ME@!] )  9 !^ (P ,0!_ (<   "  (  ]P!X *\ Q0!Y *< E ![ )\ 8@!\
M )< ,0!^ (\   "  (  ] !V ,, PP!X +< D@!Y *P 80![ *  , !] )4
M  "  (  \@!T -4 P0!V ,8 D !X +@ 8 !Z *D +P!\ )D   "  (  \ !R
M .0 P !T -, CP!W ,( 7P!Y +  +@!\ )L   "  (  W "2 '\ KP"/ '\
M@@", '\ 50") (  * "& (    "  (  V0"/ )0 K0", )$ @ "* (T 5 "'
M (H )P"% (8   "  (  U@", *D J@"* *( ?@"( )L 4@"& )0 )@"$ (T
M  "  (  TP"* +L J "( +$ ? "' *< 40"% )P )0"# )$   "  (  T@"(
M ,H IP"' +T ? "% +  4 "$ *0 )0"# )0   "  (  T0"' -< I@"& ,@
M>P"% +D 4 "# *H )0"" )8   "  (  O0"E '\ E0"? '\ ;@"8 '\ 1@"2
M (  'P", (    "  (  N@"B )$ DP"< (X ; "6 (L 10"0 (@ '@"+ (4
M  "  (  N "? *, D0": )T :@"4 )< 1 "/ )$ '0"* (H   "  (  M@"=
M +, D "8 *H :0"3 *$ 0P". )D ' ") (T   "  (  M0"< ,  CP"7 +4
M:0"2 *H 0@". )\ ' ") (\   "  (  M "; ,L C@"6 +X : "2 +$ 0@"-
M *0 ' "( )    "  (  H0"V 'X ?@"M 'X 6P"C '\ .0": '\ %@"1 '\
M  "  (  GP"T (X ?0"K (P 6@"B (D . "9 (< %0"0 (0   "  (  G0"R
M )X >P"I )D 60"A )0 -P"8 (X %0"0 (<   "  (  G "P *P >@"H *0
M6 "? )T -@"7 )4 % "/ (H   "  (  FP"O +< >0"G *X 5P"? *0 -@"7
M )H % "/ (L   "  (  FP"N ,  >0"F +4 5P"> *H -@"6 )T % ". (P
M  "  (  BP#& 'T ; "Z 'X 30"N 'X +@"B '\ #P"5 '\   "  (  B@##
M (P :P"W (H 3 "L (@ +@"@ (8 #P"4 (,   "  (  B0#! )H :@"V )8
M3 "K )$ +0"? (T #P"3 (4   "  (  B #  *8 :@"U )\ 2P"J )D +0"?
M )( #P"3 (<   "  (  B "^ +  :@"S *@ 2P"I )\ +0"> )8 #P"2 (@
M  "  (  AP"^ +@ :0"S *X 2@"I *4 + "> )@ #@"2 (@   "  (  >@#3
M 'T 7@#% 'X 0@"V 'X )@"H '\ "P"7 '\   "  (  >0#0 (H 70#" (@
M00"T (< )0"G (4 "P"6 ((   "  (  >0#. )< 70#! ), 00"S (\ )0"F
M (L "P"5 (0   "  (  >0#, *$ 70"_ )L 00"R )8 )0"E (\ "P"5 (4
M  "  (  > #+ *H 7 "^ *, 00"Q )P )0"D )( "P"4 (8   "  (  > #+
M +$ 7 "^ *D 00"Q *  )0"D )0 "P"4 (8   "  (  Y0!Y ', M@!Z '4
MB ![ '< 60!] 'H *P!^ 'P   "  (  X !S (H L@!U (@ A0!X (< 5P!Z
M (4 *0!\ (,   "  (  W !N *  KP!Q )H @@!T )4 50!W (\ * !Z (H
M  "  (  V !J +0 K !N *L ?P!R *( 4P!U )D )P!Y )    "  (  U@!H
M ,4 J@!L +D ?@!P *T 4@!T *$ )@!Y ),   "  (  U0!F -( J0!J ,0
M?0!O +8 4@!S *@ )@!X )8   "  (  Q "* ', FP"( '4 <@"' '< 2@"%
M 'H (0"# 'P   "  (  P "% (< F "$ (8 < "# (4 2 "" (, 'P"" ((
M  "  (  O0"! )H E0"! )8 ;@"! )$ 1@"  (T 'P"  (@   "  (  NP!^
M *P E !^ *0 ; !_ )T 10!_ )4 '@!_ (P   "  (  N0![ +L D@!\ +$
M:P!] *< 1 !^ )P '0!^ (\   "  (  MP!Z ,< D ![ +L :@!\ *\ 0P!]
M *( '0!^ )    "  (  I@"< ', @@"7 '4 7P"2 '< .P"- 'H %P") 'P
M  "  (  HP"7 (0 @ "3 (, 70"/ (, .@"+ (( %@"' ($   "  (  H0"4
M )4 ?@"1 )$ 6P"- (X .0"* (H %@"& (8   "  (  GP"1 *4 ?0". )\
M6@"+ )@ . "( )( %0"% (D   "  (  G@"/ +$ ? ", *D 60"* *  -P"'
M )@ %0"% (L   "  (  G0"- +L >P"+ +$ 60") *< -P"& )P %0"$ (L
M  "  (  C "L '( ;0"D '0 3@"= '< +@"5 'D $ "- 'P   "  (  B@"I
M (( :P"B (( 3 "; ($ +@"4 ($ #P", (    "  (  B "E )$ :@"? (X
M2P"8 (L +0"2 (@ #P"* (0   "  (  AP"C )X :0"= )D 2@"7 )0 + "1
M (\ #@"* (8   "  (  A@"A *D : "; *( 2@"6 )L + "0 ), #@") (<
M  "  (  A0"@ +$ 9P": *D 20"5 *  *P"/ )8 #@") (@   "  (  =P"[
M '$ 6P"Q '0 0 "G '8 ) "< 'D "P"/ 'T   "  (  =@"X '\ 6P"N '\
M/P"E '\ ) "; '\ "P". (    "  (  =0"U (T 6@"L (L /P"C (D (P":
M (8 "@"- ((   "  (  = "R )@ 60"I )0 /@"A )  (P"8 (P "@", (0
M  "  (  = "Q *( 60"I )P /@"@ )8 (P"8 (\ "@", (4   "  (  <P"O
M *D 6 "G *( /0"? )L (@"7 )$ "@"+ (4   "  (  9P#( '  3@"\ ',
M-0"O '8 '0"C '@ " "0 'T   "  (  9@#$ 'T 30"X 'X -0"M 'X ' "A
M '\ " ". '\   "  (  9@#! (D 30"V (< -0"K (8 ' "? (0 " ". ($
M  "  (  90"_ )0 30"T )$ - "I (T ' "> (D " "- (,   "  (  90"]
M )P 30"R )< - "H )( ' "= (P " ", (,   "  (  90"\ *, 30"R )T
M- "G )< ' "= (X " ", (0   "  (  S0!R &@ HP!T &P > !W '  3@!Y
M '0 (P!\ 'D   "  (  R !J 'X G@!N 'X =0!R '\ 2P!U '\ (@!Y '\
M  "  (  PP!D )( F@!I (\ <@!N (P 20!R (D ( !W (8   "  (  P !?
M *8 F !E )\ < !J )D 2 !P )( 'P!V (L   "  (  O@!; +8 E@!A *T
M;@!H *, 1P!N )H 'P!T (\   "  (  O !8 ,, E0!? +< ;0!F *P 1@!M
M *  '@!T )$   "  (  K@"" &@ B0"" &P 9 "! '  /P"! '0 &@"! 'D
M  "  (  J@!\ 'L A@!] 'P 80!] 'T /0!^ 'X &0!_ 'X   "  (  IP!V
M (X @P!X (P 7P!Y (D / ![ (< & !] (0   "  (  I !Q )\ @0!T )H
M70!V )0 .@!Y (\ %P![ (@   "  (  H@!N *P ?P!Q *0 7 !T )T .0!W
M )4 %@!Z (H   "  (  H0!L +@ ?@!O *X 6P!S *4 .0!V )L %@!Z (P
M  "  (  D@"3 &@ <@"0 &P 4@", '  ,0") '0 $0"& 'D   "  (  CP"-
M 'D ;P"+ 'H 4 ") 'L , "& 'T $0"$ 'X   "  (  C "( (D ;0"' (<
M3@"% (8 +@"$ (0 $ "" ((   "  (  B@"$ )@ :P"# )0 3 "# )  +@""
M (P #P"! (4   "  (  B0"! *0 :@"! )X 3 "! )@ +0"  )$ #P"  (<
M  "  (  B !_ *X :@!_ *8 2P!_ )X +0"  )4 #P"  (@   "  (  >0"C
M &< 70"= &L 00"7 '  )0"1 '0 "P"( 'D   "  (  =P"> '8 6P"9 '@
M0 "4 'D ) ". 'L "P"' 'X   "  (  =0"9 (0 6@"5 (, /P"0 (, (P",
M (( "@"% ($   "  (  = "6 )$ 60"2 (X /@". (L (P"+ (@ "@"% (,
M  "  (  <P"3 )P 6 "0 )< /0", )( (@") (T "@"$ (0   "  (  <@"2
M *0 5P"/ )X /0", )@ (@") )  "@"$ (4   "  (  90"Q &8 30"I &H
M- "@ &\ ' "8 ', " "* 'L   "  (  9 "L '0 3 "D '8 ,P"= '@ &P"5
M 'H !P"( 'X   "  (  8@"H ($ 2@"A ($ ,@": ($ &@"3 (  !P"' (
M  "  (  8@"E (P 2@"? (H ,@"8 (@ &@"2 (8 !P"' ((   "  (  80"C
M )4 20"= )$ ,0"7 (X &@"1 (D !P"& (,   "  (  80"A )P 20"; )<
M,0"6 )( &@"0 (L !P"& (,   "  (  50"] &4 /P"R &H *@"H &X % "=
M ', !0"* 'L   "  (  5 "Y '$ /@"O '0 *0"E '8 $P"; 'D !0") 'X
M  "  (  5 "U 'T /@"L 'X *0"C 'X $P": '\ !0"( (    "  (  4P"R
M (@ /@"I (< * "A (4 $P"8 (, !0"( ($   "  (  4P"P )  /@"H (T
M* "? (H $P"7 (8 !0"' ((   "  (  4P"N )8 /@"F )( * "> (X $P"6
M (@ !0"' ((   "  (  N0!K %X D@!O &0 :P!R &H 1 !V '  '0!Y '4
M  "  (  M !B ', C@!G '4 : !L '< 0@!R 'H ' !W 'P   "  (  KP!:
M (< B@!A (8 90!G (4 /P!N (, &@!T ((   "  (  JP!3 )D A@!; )4
M8@!C )  /0!J (P &0!R (<   "  (  J0!. *D A0!7 *( 80!? )L / !H
M )0 & !Q (H   "  (  IP!* +8 @P!3 *T 7P!= *, / !F )H & !P (P
M  "  (  G ![ %X >@!\ &0 6 !] &H -@!^ '  % !^ '4   "  (  F !R
M '$ =P!T '0 5@!W '8 - !Y 'D $P!\ 'L   "  (  E !K (, <P!O ((
M4P!R (( ,@!V ($ $@!Z ($   "  (  D0!E ), <0!J )  40!N (P ,0!S
M (D $0!Y (0   "  (  CP!A *  ;P!F )H 4 !L )4 , !Q (\ $0!Y (<
M  "  (  C0!> *L ;@!D *0 3@!J )P +P!P )4 $ !X (@   "  (  @0"*
M %X 9 "( &0 1@"' &H *0"% '  #0"" '8   "  (  ?@"# &\ 80"" '(
M1 "" '4 * "! '@ # "! 'P   "  (  >P!] 'X 7P!^ 'X 0P!^ '\ )@!_
M '\ # !_ (    "  (  >0!X (T 70!Y (L 00![ (D )0!\ (8 "P!^ ((
M  "  (  =P!T )@ 6P!V )0 0 !X )  ) !Z (P "P!^ (0   "  (  =@!Q
M *( 6P!T )P /P!V )8 ) !Y )  "P!] (4   "  (  :0": %T 4 "6 &,
M-P"1 &D '@", &\ " "% '@   "  (  9@"3 &P 30"0 &\ -0", ', ' ")
M '8 " "# 'P   "  (  9 ". 'H 3 ", 'L ,P") 'P &P"' 'T !P"" '\
M  "  (  8P") (8 2P"' (4 ,P"& (0 &P"$ (, !P"" ($   "  (  8@"&
M )  2@"% (T ,@"$ (H &@"# (< !P"! ((   "  (  80"$ )D 20"# )4
M,0"# )  &@"" (H !P"! (,   "  (  50"H %P /P"A &( *@": &@ % "3
M &\ !0"& 'D   "  (  5 "B &D /@"< &T *0"6 '$ $P"0 '4 !0"% 'P
M  "  (  4@"< '8 /0"7 '@ * "2 'D $P"- 'L !0"$ '\   "  (  40"8
M ($ / "4 ($ )P"0 ($ $@"+ (  !0"# (    "  (  40"5 (H / "1 (@
M)P". (< $@"* (0 !0"# ($   "  (  4 "3 )$ .P"0 (X )@", (L $@")
M (8 !0"" ((   "  (  10"T %H ,@"K &$ 'P"B &< #0"7 &X ! "' 'H
M  "  (  10"N &< ,@"F &L 'P"> '  #0"4 '4 ! "& 'T   "  (  1 "I
M ', ,0"B '4 'P"; '@ #0"2 'L  P"% '\   "  (  1 "E 'T ,0"? 'X
M'P"8 'X #0"0 '\  P"$ (    "  (  0P"B (4 , "< (0 '@"6 (, # ".
M ((  P"$ (    "  (  0P"@ (L , ": (D '@"5 (< # "- (,  P"$ ($
M  "  (  J@!F %8 A@!K %T 80!O &0 /0!S &P &0!X ',   "  (  I !;
M &L @0!A &\ 70!H '( .@!N '8 %P!U 'D   "  (  H !1 'X ?0!9 'X
M6P!A '\ . !I '\ %@!S '\   "  (  G !( )  >@!2 (T 6 !; (H -@!E
M (@ % !Q (0   "  (  F0!" )\ > !- )H 5@!7 )0 -0!B (\ $P!Q (<
M  "  (  EP ] *P =@!) *0 50!4 )T - !@ )4 $P!P (D   "  (  C@!T
M %< ;@!V %X 3P!X &4 +P!Z &P $ !] ',   "  (  B@!J &D :P!N &T
M3 !R '$ +@!U '4 #P![ 'D   "  (  A@!B 'H : !G 'L 2@!L 'P + !R
M 'T #@!Y 'X   "  (  @@!: (H 90!A (@ 1P!G (< *@!N (4 #0!X ((
M  "  (  @ !5 )< 8P!< ), 1@!D (\ *0!K (L #0!X (0   "  (  ?P!1
M *( 8@!9 )P 10!A )8 * !I )  #0!W (8   "  (  = "# %< 60"" %X
M/@"" &4 (P"! &P "@"! '4   "  (  < ![ &< 5@!\ &L .P!] '  (0!^
M '0 "0!_ 'H   "  (  ;0!S '8 4P!U '@ .0!W 'D ( !Z 'L "0!^ 'X
M  "  (  :P!M (0 4@!P (, . !T (, 'P!W (( "0!] ($   "  (  :0!H
M (\ 4 !L (P -P!P (H '@!T (< " !\ ((   "  (  : !D )@ 3P!I )0
M-@!N )  '0!R (L " !\ (,   "  (  7 "3 %8 10"0 %T +@", &0 %P")
M &P !@"# '<   "  (  6@"* &0 0P"( &D +0"' &X %@"% ', !@"! 'L
M  "  (  6 "$ '( 0@"# '0 + "# '< %0"" 'D !@"  'X   "  (  5@!^
M 'X 0 !^ 'X *@!_ '\ % !_ '\ !0"  (    "  (  50!Z (@ /P![ (<
M*@!\ (4 % !] (, !0!_ ($   "  (  5 !W )  /@!Y (T *0!Z (H $P!\
M (8 !0!_ ((   "  (  20"@ %0 -0": %P (@"5 &, #P". &L ! "$ '@
M  "  (  1P"9 &$ - "5 &8 ( "0 &P #@"+ '( ! "# 'L   "  (  1@"2
M &X ,P"/ '$ ( ", '0 #@"' '@ ! "" 'X   "  (  10"- 'D ,@"+ 'H
M'P") 'L #0"% 'T ! "! '\   "  (  1 ") ($ ,0"' ($ 'P"& ($ #0"#
M (   P"! (    "  (  1 "& (@ ,0"% (< 'P"$ (4 #0"" (,  P"! ($
M  "  (  .0"M %( * "E %H %P"> &( "0"1 &P  @"% 'D   "  (  . "E
M %\ )P"? &4 %P"8 &H "0"- '(  @"# 'P   "  (  . "? &H )P": &X
M%P"4 '( "0"* '@  @"# 'X   "  (  -P": '0 )@"5 '8 %@"1 '@ "0"(
M 'P  @"" '\   "  (  -P"6 'P )@"2 'T %@". 'T "0"' '\  @"" (
M  "  (  -@"4 (( )@"1 (( %0"- ($ " "& ($  @"" (    "  (  GP!A
M %  ?0!F %@ 6@!L &$ . !Q &D %0!W '$   "  (  F0!4 &0 > !< &D
M5@!C &X -0!K '( $P!T '<   "  (  E !) '< <P!2 'D 4P!< 'H ,@!E
M 'P $@!S 'T   "  (  D  _ (D < !* (< 4 !5 (8 , !A (0 $0!R ((
M  "  (  C0 W )@ ;@!$ )0 3@!0 )  +P!= (P $ !Q (4   "  (  BP Q
M *0 ;  _ )X 30!, )@ +@!: )$ #P!P (<   "  (  A !O %$ 9@!R %D
M2 !U &$ *P!X &D #@!\ '(   "  (  ?P!D &, 8@!I &@ 10!N &T * !S
M '( #0!Z '@   "  (  >P!9 '0 7P!@ '8 0P!F '@ )@!M 'H # !Y 'T
M  "  (  =P!1 (, 6P!9 (( 0 !A (( ) !I ($ "P!X ($   "  (  =0!*
M )  6@!3 (T /P!= (H (P!F (@ "@!W (,   "  (  <P!% )L 6 !/ )8
M/0!9 )( (@!D (T "@!W (0   "  (  :@!^ %$ 40!^ %D -P!_ &$ '@!_
M &D " "  '0   "  (  9@!S &$ 30!U &8 -0!W &P ' !Z '$ " !^ 'D
M  "  (  8P!J '  2P!N ', ,P!R '8 &P!U '@ !P!] 'T   "  (  8 !C
M 'T 2 !H 'X ,0!M 'X &0!R '\ !P!\ (    "  (  7P!= (@ 2 !C (<
M, !I (4 &0!P (0 !P!\ ($   "  (  70!9 )$ 1@!@ (X +P!F (L & !O
M (< !@![ ((   "  (  4P", %  /@"* %@ * "( &$ $P"& &D !0"" '8
M  "  (  4 "# %X .P"# &0 )@"" &H $@"! '  !0"  'H   "  (  3@![
M &L .@!\ &\ )0!] '( $0!^ '8 ! "  'T   "  (  3 !T '< . !V 'D
M) !X 'H $ ![ 'P ! !_ '\   "  (  2P!O ($ -P!R ($ (P!U ($ $ !Z
M (  ! !^ (    "  (  2@!K (D -@!O (< (@!R (8 #P!Y (, ! !^ ($
M  "  (  /P": $X +0"6 %< &P"1 %\ "P"* &D  P"# '@   "  (  /@"1
M %L + ". &$ &P"+ &@ "P"& '   P"" 'L   "  (  / ") &< *P"' &L
M&0"& '  "@"# '8  P"! 'T   "  (  .P"# '( *@"" '0 &0"" '< "@"!
M 'L  P"  '\   "  (  .@!^ 'L *0!^ 'P & !_ 'T "@"  'X  P"  (
M  "  (  .@![ ($ *0!\ ($ & !] ($ "@!_ (   P"  (    "  (  +P"G
M $P ( "@ %4 $0"9 %X !P", &H  @"# 'D   "  (  +@"> %@ 'P"9 %\
M$ "3 &8 !P"( '   @"" 'P   "  (  +@"7 &, 'P"3 &@ $ "/ &T !P"&
M '8  @"" 'T   "  (  +0"0 &T '@"- '  $ "* '0 !@"$ 'H  @"! 'X
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M*BLK+"PM+2XN+R\P,#$Q,C(S,S0T-34V-C<W.#@Y.3HZ.SL\/#T]/CX_/T!
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M%AK_ ,]2,V.#7YLO]S@R'SG6*/\ LB9_[!QLF"$/KG'W1N1^S;[61V-EJ]^
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M/Y8U/4+V>]U 6;I>&'BJ^B\E1Z:*:U4=\]#_ .!S_P $;4^TVIGAS0A$1AQ
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M?6T<R$^!,9B('O0T\#F=HO\ @\YXG]_@B1_0D8G_ &7'?V-&;V$@1^[R$'S
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MW_1,3R'_ -7_ %S[[;_JEC_R?;7_ .I8O]G_ ,4O^@;!_/G]GZG?]#3>8/\
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MU2%0TEM;33*K="8T+ &G;;/L;_T3$\A_]7_7/OMO^J6?-/\ R?;7_P"I8O\
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M165)*\3R=5WH0>_CGU6_Z)B>0_\ J_ZY]]M_U2SY^_Y/MK_]2Q?[/_BGO_\
M0-@_GS^S]3Y+_P"AIO,'_5NL/NE_YKS?]$Q/(?\ U?\ 7/OMO^J6/_)]M?\
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M>\\MW;ECITB/#4[B*:IXCV#*3_LL^:F>X/$/IW-BKLV*NSHOY/\ _*>>5O\
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M8]T2!S?*T<;2GC&"2 6H/!14GZ *XMD62S/FI_S\[_Y0/0/^VX/^H:7/</\
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M.U 1058$YXN_Y7!Y\_ZFG7/^XE<_\UYZ?_H;T'^H8O\ E7#]3S/\HY_Y\_\
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MXY[2:G)#69 )$"QU/<'Z.?DQHFG77DO29[FTMY)6BDY,\2,Q_>OU)%<\T?\
M*P/-'_5[U+_I,F_YJSN?Y'TO^I0_TD?U.C_.9?YTOF7J'^'=*_Y8;7_D2G],
MW_*P/-'_ %>]2_Z3)O\ FK'^1]+_ *E#_21_4OYS+_.E\R[_  [I7_+#:_\
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M3SE_S#:=_P 3FSY]_P"#W_=:;^MD^Z#W_L']63W1_2^2?^<K/]Y=%_XRW/\
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MK2:?9?4P/M$\;HD#I^V(^_AG@G_!NWGHQ/Z#.?%_TK_WO$]Y[$[#,1]5"O\
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M #CGY,UORK<:K)YBLI;19HX!&9 !R*EZTH>U1GS!SWAX5]3YL5=FQ5V?4/\
MY]??\I1YI_[9MO\ \GL\&_X//^*X/Z\O]R]W["?WL_ZH^]\J_P#.5/\ QRM*
M_P"8J3_B&?9[/F-],?$N?(__ )^G?],)_P!OK_L3SZ*_X /_ "*_Y(_]/7SO
MV]_R7^?_ +U]A?\ .)__ $O_ /HQ_P"9V?([/HM\\?86;%79L5=FQ5V;%79L
M5=G1?R?_ .4\\K?]MS3?^HE,TOM)_B&?_A63_<%S>SO[^']>/WAC?G/_ )1_
M5?\ F NO^339^IS/@1]Z?D_G(_\ G(#_ ,E?YV_\!K6/^H.7.B]C_P#C3TW_
M  _%_P!-(NN[7_Q;+_4G_N2S'\O/^4JT+_MIV7_)]<_+UGWF^$OU3S8J[-BK
MLV*NSZL_\^M_^.IYR_YAM._XG-GS[_P>_P"ZTW];)]T'O_8/ZLGNC^E\D_\
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M?\G7SR]G>NB>JYL5=FQ5V;%79L5=GOW_ )]N_P#DV9O^V'>?\G8<\@_X-O\
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M ,[#SC0]O9_8+19-+KI1F8W^6 E<Y@D[2CSA 'U6>0)@-Q$/19]#C[>S1RX
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MY_XBF?8C/FQ](?&.?FM\_>?=8_+#\\O,_GKRE-Z&IZ?YJU>6,FO%Q]<E#QN
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M78,T_3[G5KJ#2],B>>\N94AABC!9WD=@JJH&Y))  \<KS9HX8F<R!&())/(
M;DGR 90@9D1&Y.P4;BXBM(I+NZ=8X8E9W=C0*JBI)/@!GZ2?^<7OR)MOR#\D
MVWEN14?7;NEWJUPN_.X8?8![I$/@7L:,] 7.?$?M[[62]H];+,+\./IQQ[H#
MK_6F?4?A'^$/M?8790[.PB'\1WD?/N]PY?;U?F7^:OGZ7\P=<EU-2PL(:PVD
M9_9C!^T1_,Y^(_0O[(SI7YI_F5I'Y1^5]0\_>:'XV=A$66,$!YI3M'$G^4[4
M \/M'X03FB[ [#S=M:J&EPCU3//I&/\ %(^41O\ 8-RYVOUL-%B.6?(?:>@'
MO8QY3\L7GG'5;;R]I2UFN'H6ILB#=G;V4;_@-SGP[_YQX_,+5_S5_P"<CM#\
M^^:9/4U#4+^YD8 GC&@M90D:5Z(B@*H\!OOGU7[9]C8NQ_9W+I< J,(1'F3Q
MQN1\Y'<OEG8VLGK.T8Y9\R3\/2:'N#[N_,?RY9^4_P M+_R_I*\;>VMXE!/5
MCZR%F;W8U)S] V?'CZ^_.[/FI_S\[_Y0/0/^VX/^H:7/</\ @$_X_E_X5_OX
MO$>W/]Q#^O\ H+Z>_P"<6?\ E(-1_P"8 _\ )U,^).?4KY>^YLV*NS8J[-BK
ML_13_P X)_\ DCO*W_;R_P"ZE<Y\7_\ !9_XV\__ "3_ .F6-]E]E/\ $H?Y
MW^[D_-S\_/\ E/-6_P"C7_J&BSUQGG3T3Q[/SQ_\YB>3=?U+\X_-5]IVE7UQ
M;27,!26*VE=& MHALRJ0=\^R_P#@:]IZ?%V/@C/) $1E8,@#]<NA+XY[2:;)
M/69"(DBQT/<'Z.?DQK>G6ODO28+F[MXY5BDY*\J*P_>OU!-<\T?\J_\ -'_5
MDU+_ *0YO^:<[G^6-+_JL/\ 3Q_6Z/\ )Y?YLOD7J'^(M*_Y;K7_ )')_7-_
MRK_S1_U9-2_Z0YO^:<?Y8TO^JP_T\?UK^3R_S9?(N_Q%I7_+=:_\CD_KF_Y5
M_P":/^K)J7_2'-_S3C_+&E_U6'^GC^M?R>7^;+Y%W^(M*_Y;K7_D<G]<W_*O
M_-'_ %9-2_Z0YO\ FG'^6-+_ *K#_3Q_6OY/+_-E\B[_ !%I7_+=:_\ (Y/Z
MYO\ E7_FC_JR:E_TAS?\TX_RQI?]5A_IX_K7\GE_FR^1=_B+2O\ ENM?^1R?
MUR4^4OR+_,#SQ?Q:-Y<\MZG--*X4NUK+'$E33E)(ZA$45W+$9K^T?:S0=GXS
MDS9L8 Z<0,CY1B"3(^0#D:?LK4:B7#"$OD:^)Y!*=8\^^7="MWO=2U.U1%!/
M$2JSM3LJ@DL?8#/TN?E_Y8_P3Y7T3R89!+^B--L]/]0=&^K0K%R^GC7/ASMC
M7_G]5EU%5XDYSKNXY&5?:^W:/!X&*./^;$1^0I^8/F+5?TYJM]K87A]<NIKC
MCX>JY:GT5P\UG5K70-/N]=U60165E!+<SR'HL<2EW8_( G,33:>6IR1Q0%RD
M1$#O,C0'S;<N08XF4N0!)]P0%E9RZA<0V%HO.>>18HU'=G- /I)S\HNNZHVN
M:E>:U(H1KRXEN"HZ*9'+4'RKGZ#Z3!^7QQQC?AB(_(4^ 9<GB2,N\D_-^N%A
M:"PM8+%3R$,:1@GOQ %?PPJS(:T7FQ5V;%79]S?^?9?_ )*_5O\ P);K_J#M
M,^4O^#I_QIX_^$1_Z:97U3V'_P 6E_7/^YB^#?\ G*+_ )2JS_[9D7_)^;/H
MIGB[V;YMSX*?\_"-)OKS\WKF:TMII8_T;8CDD;,*A3W SZX_X#FHA#LB(E(
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M79L5=FQ5V;%7Y'?\YC_^3+G_ .V98_KES8J^4).V;%4#)FQ5 2=\V*H&3O\
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M (ZGG+_F&T[_ (G-GS[_ ,'O^ZTW];)]T'O_ &#^K)[H_I?)/_.5G^\NB_\
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M )P_\LVF_P#2<G],ZG_D\W9'\Z?^D/ZW5_Z#=7W1_P!,SO\ Z&0\F?[]NO\
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M R&7)'%$RD: !))Y #F2RC$R-#F5.::.WC>XG8)%&I9F8T 4"I)/@!GZ8_\
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M[?\ G&W_ )53YA_Y6-Y2M^'E/79F+I&/@M+UJL\=.BI)N\8Z"CH %5:_6O\
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M$OOS._+>RBL/-&GQ275U;VR!([Z)!RDJBT F5065E%9#5&!9E9?:_P#@9_\
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M_(?K95_T+-YO_GL/^1S_ /-&;_HI%^4W^^=<_P"D.+_JMC_R9+M7OQ?Z<_\
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M2<LPX99I"$ 92)H "R2>@ YL)S$!Q2- <R5:VMI;R5+6TC:6:1@J(@+,Q/0
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M_6R?=![_ -@_JR>Z/Z7R3_SE9_O+HO\ QEN?^(IGV(SYL?2'QCGP;_Y^1?\
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M&_.?_*/ZK_S 77_)IL_4YGP(^]/R?SD?_.0'_DK_ #M_X#6L?]0<N=%['_\
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M';_$,7_#?]Y)[?V&_OY_U/TA\Q?\Y3?\H_IW_,>/^33Y]ML^6WU!\,9\,O\
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MY3?\_2/^.7Y-_P"8G4?^(0Y]!?\  $_O=3_5Q_?-X#V\^G'[Y?H?6W_.*?\
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M#_R5_G;_ ,!K6/\ J#ESHO8__C3TW_#\7_32+KNU_P#%LO\ 4G_N2S'\O/\
ME*M"_P"VG9?\GUS\O6?>;X2_5/-BKLV*NS8J[/JS_P ^M_\ CJ><O^8;3O\
MB<V?/O\ P>_[K3?ULGW0>_\ 8/ZLGNC^E\D_\Y6?[RZ+_P 9;G_B*9]B,^;'
MTA\8Y^7K_G(#_P FAYV_\"76/^HR7/O+V/\ ^,S3?\(Q?],XOA/:_P#C.7^O
M/_=%^JGY>?\ **Z%_P!LRR_Y,+G(\Z-US,,V*NST+_SC1^?%_P#D!YQ@\S0E
MY=%NJ6VJVB_[MMR?M*#MZD9^)#MW6O%VSC?;GV2Q^TFC.$T)Q]6.7\V?<?Z,
MN4O@><0[CL/M:79V83_A.TAWC]8YCY=7G/YH>0+?\P]%DTM^*7T59;28_L2
M="?Y6Z-]_4#/TD:)K=AYDT^U\P:#<)=:=>PI/;SQ&J21R#DK ^!!SXCU6ER:
M7)+%E!C*),9 \P1L0^UXLL<L1*)L$6#Y/S,OK&XTRXET[4(VBN8':.2-A0JR
MFA!PS) %3L!E#-" 5V&? +_G.#_G([_E<WF@>4O+$_/RCH,KI R'X;JZW62X
MVV*@?!%_D\F!_>4SZ_\ ^!7[$_R%I?'S#]]E )OG"'.,/(_Q3\Z'\+Y'[4]M
M?GLOAP/HAR_I2ZR_0/GU?H9^1/Y:?X)TK],:K'36-056<$;Q1=5C]B>K^]!^
MSGAS/5GE7O&;%79ZA_YPN_\ )T^4O^8FX_ZA9<X+_@G_ /&-J/ZL?]W%WOLS
M_CF/WG[B\J_.[_E"-7_XQ1_\G4S](&?$[[4_-#/FI_S\[_Y0/0/^VX/^H:7/
M</\ @$_X_E_X5_OXO$>W/]Q#^O\ H+Z>_P"<6?\ E(-1_P"8 _\ )U,^).?4
MKY>^YLV*NS8J[-BKL_13_P X)_\ DCO*W_;R_P"ZE<Y\7_\ !9_XV\__ "3_
M .F6-]E]E/\ $H?YW^[D_-S\_/\ E/-6_P"C7_J&BSUQGG3T3Q[/S?\ _.:/
M_DZ?-O\ S$V__4+%GVQ_P,/^,;3_ -67^[D^*^TW^.9/>/N#]+_R1_Y0C2/^
M,4G_ "=?/+V=ZZ)ZKFQ5V;%79L5=FQ5V;%79^D;_ )PU@DMOR8\I1S#BQLY7
M J#\+W$C*=O$$'/B3_@F3$NV=01_. ^48@_:^U>S0K1X_<?O+\S?SKD67SMK
M#(:@3(OTK&H/XC/3><*[UY;GYD?^<F__ ";/G/\ [;E[_P G3GW5["_\96F_
MX5#[@^&]N?XUD_KG[WZD?E=_RB&B?\P$'_$!G#,ZMU3/,V*NS8J[/N;_ ,^R
M_P#R5^K?^!+=?]0=IGRE_P '3_C3Q_\ "(_]-,KZI[#_ .+2_KG_ ',7P;_S
ME%_RE5G_ -LR+_D_-GT4SQ=[-\VY\!/^?B'_ ).&Y_[9MC_Q Y]??\!G_C(C
M_7G]X?(O;+_&S_5B_0O_ )QO_P"4,B_YBI_UC/#.>KO*O><V*NS8J[-BKLV*
MNS8J[-BKLV*NS8J[-BKLV*NS]%/_ #@G_P"2.\K?]O+_ +J5SGQ?_P %G_C;
MS_\ )/\ Z98WV7V4_P 2A_G?[N3\W/S\_P"4\U;_ *-?^H:+/7&>=/1/'L_-
M_P#\YH_^3I\V_P#,3;_]0L6?;'_ P_XQM/\ U9?[N3XK[3?XYD]X^X/TO_)'
M_E"-(_XQ2?\ )U\\O9WKHGJN;%79//RT_,G7?RE\Q6?GGR9<&#4;1NAJ8Y8S
M]N*501R1QL1\B"& (U';G8F#MG3RTVH%QE\XGI*)Z2'0_ V"0Y>AUL]'D&3&
M:(^WR/D6/^:/+-AYOTV;0=;C]2VF'4?:1AT=3V8=C]!VJ,_1I^07Y\:#^?WE
MJ/S3Y>817\(2/4;!FK):SD?9/3DC4)C>E''@RLJ_%?M?[)9_9O4G!EWB;,)]
M)Q[_ "D/XH]#Y$$^S]D=K8^T<?'#G_$.L3^KN/7YOS7_ #"\@:A^7NIMI6I
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M]N/\9C_4'^ZD^\_^<7?^45O/^VG+_P F(<^=>>T/&OI'-BKLV*NS8J[/9_\
MSBE_SESJOY"7J>6M?YW_ )'NIN4]ONTEJS?:EMZFG7=X^CTVXL>1\Q_X(/\
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M[?:I_ON4[]I!L,V*L'T/4(-0#B LLL+F*:&12DL4@ZI)&U&5AX$?+-BKU/\
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MEW'Y._2-K_O^+_@U_KF_P_JG_+#<_P#(E_Z8_G,7\Z/S"^#+N/R=^D;7_?\
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MF=?EA!]9\W:)'0FFH6[[?Y#AOX9^8W/NQ\-?J5FQ5V;%79L5=GU9_P"?6_\
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M$G/J5\O?<V;%79L5=FQ5V?HI_P"<$_\ R1WE;_MY?]U*YSXO_P""S_QMY_\
MDG_TRQOLOLI_B4/\[_=R?FY^?G_*>:M_T:_]0T6>N,\Z>B>/9^;_ /YS1_\
M)T^;?^8FW_ZA8L^V/^!A_P 8VG_JR_W<GQ7VF_QS)[Q]P?I?^2/_ "A&D?\
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MBKLV*NS8J[-BKLV*NS8J[/T4_P#."?\ Y([RM_V\O^ZE<Y\7_P#!9_XV\_\
MR3_Z98WV7V4_Q*'^=_NY/S<_/S_E/-6_Z-?^H:+/7&>=/1/'L_-__P YH_\
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MFXV96\05&Q5]SV=U%?017MJP>&9%D1AN"K"H(^8.;%41FQ5V;%79L5=GJ/\
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M'_=Q=[[,_P".8_>?N+RK\[O^4(U?_C%'_P G4S](&?$[[4_-#/FI_P _._\
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MR2=R3N3GO&/'''$1B  !0 V  Y #N>$E(R-GF^J8HD@18(%5(T4*JJ   !0
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M )L/]./U+_HRTG?+_2N_Z%P\Y_[ZM?\ I('],W_11#\GO^6K4O\ I!?^N/\
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M9:3OE_I7GG_0N'G/_?5K_P!) _IGQS_YR0\^:5^9OYD:_P">O*S2/I6H31/
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MVO\ S8?Z<?J7_1EI.^7^E=_T+AYS_P!]6O\ TD#^F;_HHA^3W_+5J7_2"_\
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MJ-C[9L51:9L51J9L51L>;%4:F;%4:F;%7Z4_\X%?\<_S-_S%6?\ R;?-BK]
M,V*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKL4AAD
MN)%M[=6>5V"HB@EF8F@  W))Z#(RD(BSL D"]@M=UC4R2$*J@DDF@ '<Y]<?
M^<5O^<>Q^5\0\V><U5/-=\G 1M2FG6SCXPQZ"9U^W_OM/@ZEP/G7_@@>V7\K
MGP-/_<Q-W_JLQRK^@#]/\Z7JY /H?8'8_P"4'B9/K/\ L!^OO[AMWOCK\VOS
M(_Q6_P"AM#);2;=N18?\?,HZ4'\@/V?YCOT SYE_FOYM_P =^<M=\WJ3Z6H:
MA<31 ]HBY$:_[% H^C/=/9[L[^3M'BT_6$(@_P!:O4?C*R\/VAJ/S&:63O)/
MPZ?8^I?*.C_H#1-/T8_:M[:-']W"CD?I:ISGV;APV19L5=FQ5V;%79L5=CXX
MWF=8HE+.Q"JJBI)/0 >."4A$64@6TS! 7<@*!4D] ,E?_*O_ #1_U9-2_P"D
M.;_FG-?_ "QI?]5A_IX_K;_R>7^;+Y%*/\1:5_RW6O\ R.3^N;_E7_FC_JR:
ME_TAS?\ -./\L:7_ %6'^GC^M?R>7^;+Y%W^(M*_Y;K7_D<G]<)-1T34=';A
MJ]I<6K5 I/$\9J14#X@.V^96'58\^^.0E[B#]S7/%*'U CWA'6U];7HY6<T<
MHZUC<-[=CA9E[6BLV*NS8J[-BKLV*NS8J[!EAI]UJLZ6&F02W-S)7A%"C.[4
M!)HJ@DT )/ME>;-'#'BF1$#F2:'S+*$#,U$6?)1N+B*TC-Q=2+%$M*N[!5%3
M05)VZX*U70=3T,HFMV5S9M("4%Q"\18#K3D!6E>V5Z?5XM1?ARC*N?"1*ODR
MR898_J!'O%*5IJ%K?AC8SQ3!:<O3=6I7I6A.%.9#6B\V*NS8J[)"WE'75M/T
MLVF7HL?3$WKFVD]+TR*A^?'CQIO6M*9ACM' 9^'QQXKKAXA=]U7=^3=^7G7%
MPFN=T:2T:Q8&;ZF+J S\N'I^JO+E6E*5K6O;(]F8TIEFQ5V;%79L5=FQ5V;%
M79L5=EJI<A$!+$T '4G 32M$@"IV P_U#REKFD0F]U;3+VUMU(!DGMI(T!/0
M<F4#?,3#VC@S2X83C(]PD"?D"W3T\X"Y1('F"E]MK%A>.(+2Z@ED-2%CE5CM
M[ Y'\S&E,<V*NS8J[-BKLV*NS8J[-BKL7M;6:]F2SLHWFGD8*D<:EF9CT  W
M)/@,ADR1Q@RD0 .9.P"8Q,C04Y94@1IIV5(U%69B  !W).2?_E7_ )H_ZLFI
M?](<W_-.8/\ +&E_U6'^GC^MO_)Y?YLOD4K_ ,1:5_RW6O\ R.3^N;_E7_FC
M_JR:E_TAS?\ -./\L:7_ %6'^GC^M?R>7^;+Y%W^(M*_Y;K7_D<G]<)-1T34
M=';AJ]I<6K5 I/$\9J14#X@.V^96'58\^^.0E[B#]S7/%*'U CWA'6U];7HY
M6<T<HZUC<-[=CA9E[6BLV*NS8J[-BKLV*NS8J[!-I9W&H3)96$3SW$AXI'$I
M=V/@%%23D,F6.,&4B !S)- ?%E&)D:&Y4IIH[=&GN'6.-15F8@ #W)R0S>1?
M,EO&]Q<:-J,<4:EG=K28*J@5))*T  ZG,*/:VFD:&2!)_I1_6W'29!N8R^12
MY-?TR1A''>VS.Q  $R$DGH *Y%<V#CIMFQ5V;%79L5=AWI?EK5]<1I]%T^[O
M(T/%FMX)) IZT)4&AS%SZ[#IS62<8D_SI ?>6W'@GDWB"?<"4#=ZI9V#!+ZX
MAA9A4"215)'M4C&ZKY=U70PCZW8W5FLA(0W$+Q!B.M.0%:5[8=/K<6HOPYQE
M7/A(E7R*Y,,\?U CWBF[34K2_+"QN(IBM.7INK4KTK0G";,EJ1N;%79L5=FQ
M5V;%79L5=FQ5V&&FZ3?:S-]3T>VFNYPI;TX(VD;B.IHH)IOURG/J(8!Q9)"(
M[R0!]K.&.4S403[MT/=7D%DGK7LJ0QUIRD8**^%3EZGH]_HDHM=9M9[2=E#B
M.XB:-BI) 8!@#2H(K['!@U./4#BQR$ARN)!%]VRY,<L9J0(]XIJUO;>^0S64
ML<R \2T;!@#UI45WWPNR]@B<V*NS8J[-BKLV*NS8J[-BKLV*NS8J[)GY7_+G
MS7YW-/)NAZEJHKQ)LK2:=0?=D4@>Y)VS6:_MK2]G_P",988_Z\XQ^PD6Y.#1
M9=1_=QE+W G[DDU7S+I&A;ZU?VMIM6D\R(3\@Q!.=4B_YQ-_."9%E3R?J@#"
MHY1A3]()!'TC.?E_P0^R(FOS&/YW^AV ]GM6?\G)B;_F]Y-0E#K-K4;;,2/O
M IG-_-7Y4>=/(ZF;SCY>U73(1_NV[LYHHS\G90I^@YN^S_:'1=H&M/FQS/=&
M<9'Y W]CA:CL_-I_[R$H^\$#YLFTGS=HFO'AHNHVET_\D,Z.W_ @U_#(!FX<
M-D.;%79L5=FQ5V;%79L5=AII>AZEKCO%HMG<7CQ@,ZV\3RE0>Y"@T&8^HU>/
M3B\DHQO^<0/O;,>*63Z03[A:$N[^VL 'OIHX58T!D<*"?:I&'7_*O_-'_5DU
M+_I#F_YIS&_EC2_ZK#_3Q_6V?D\O\V7R*"_Q%I7_ "W6O_(Y/ZYO^5?^:/\
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M: X0YEM*89L5=FQ5V;%79L5=FQ5V;%79L5=BL$$EU(MO;(TDKD*B("S,3T
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MV$#]*0ZK_P XN:G8J;KRYJT4\R594EC:!MN@#*S[^^WT9U/\SO\ G%/\KO\
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MN_YR2\JCSY^4*66G:K>1&>PU'3T]*VG<5K'<0J !5@5=N"RHWVJT*'0=A?\
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MF6/5))VM69A&8 H;DA7KS-.OAGSQSV9XY]'9L5=FQ5V;%79L5=GVV_Y]B?\
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M/_"I_?!]0]M?\5']<?<7PS_SC-_RE[_\P$W_ !-,^#>?6SY.^_LV*NS[Z?\
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MNM3/!KLC_$72Y?DT[?Y4<A$A(%2 ZC[6?0_MW['P[8[-.FPQ EB .$#H8"A
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MX_?+]"._YQ3_ -ZM:_XQ6W_$GSX[Y])OF[[.S8J[-BKLV*NS8J[-BKL]-_\
M.)OY'/\ GIY]M-$OHV/E_3Z7VJN!L848<8J^,K43QX\V'V<X7_@A^U0]GM!+
M)$_O)^C&/Z1&\O= ;^_A'5WGL]V5_*&<1/TC>7N[OCR^;R[\WO/:^0O+\U]
MP&HW-8+1>_-AN]/!!O\ .@[Y[X_Y^.?G7'H.CV7Y$^6I%2>_6.ZU,1$#T[6-
MOW$-!T]1UY$;45%VXOGD/_ 4]ESJ<TNT\PL0N..^LR/7/_-!J^^1ZQ>N]M.U
M/#@--#KO+RB.0^)W^'F^?/\ G&KR.VH7L_G[4U+1VY:&U+;\I6'[Q]^O$&E?
M%CW7"_\ Y]N_G:M_9WOY$^8)>4MN)+_2>9J&A8_Z1 *_RL?44;U#2'HN7_\
M!M]EO#G'M/$-C4,E?SOX)_$>DGRCWL/8KM3B!TT^F\?=_$/T_-$?\Y,^1C;S
M0>?M.6B2<;>[X]G']W)]('$GV7QSQ3_SF)^19_(_S[<6NE1</+>L<K[2R!14
M1F_>0#:G[ES0#?\ =F,G<YZA_P #7VK_ -$&@$IF\N.H9.\D?3/_ #QN?Z0E
MW/,>TG97Y#.1'Z9;Q_2/@?LI[C^3'GW_ !WY?CENWY:G9TM[JIW8@?#)_LQN
M3_,&\,\I9Z"\^];S8J[-BKLV*NS8J[-BKL^]7_.!WY/:?^5WY=I^96M*D>L^
M88/KT\\FWHV*U:% 3T5D'K,=J\@#7@N?(_\ P6_:7)VOV@='CWAA/  /XLO*
M9]X/H'N-?47UGV3[-CI-/XTOJF+)[H]/L]7Q\GY^_G_YSN/-7F1O+%B2UEIK
M^@D:[\[@[.2/$'X!\C3[1SY1?\Y-?G_JGY^^;;C69I73R[9R20Z19DD+' #0
M2%?]^2@!G)W&R5XJN?0?L+['XO9S2#& /$D <LNIE_-O^;'E'_3<R7@.W.UY
M=HY3+^$;1'<._P!YZ_+H^N/RN_+RU_+W1X[)$4ZE,JO>3=2TE/L@_P J5HOW
M]2<\Y9VKI7I6;%79L5=EEBP )) %![#K@I6@ *D=^N5A5O-BKLV*NS8J[-BK
ML^H?_/K[_E*/-/\ VS;?_D]G@W_!Y_Q7!_7E_N7N_83^]G_5'WOE7_G*G_CE
M:5_S%2?\0SA?_.?W_DZ=9_YAM/\ ^H6/.K_X#_\ QC8_ZV3_ '9=5[7?XY+W
M1^X,]_YQY_Y0BQ_XRW/_ "=;/&&>G/,O;<V*NS8J[-BKLV*NS8J[-BKLV*NS
M[;?\^Q/^4#U__MN'_J&BSY:_X.W^/XO^%?[^3ZA[#?W$_P"O^@/AG_G*;_E(
M-._Y@!_R=?/E+_SD!_Y-#SM_X$NL?]1DN?07L?\ \9FF_P"$8O\ IG%X#M?_
M !G+_7G_ +HOK;\O/^45T+_MF67_ "87.1YT;KF89L5=GN;_ )]W_P#DX;;_
M +9M]_Q 9Y1_P9O^,B7]>'WEZKV-_P ;']63P;_G)#_E#)?^8J#]9SHO_/SO
M_E/- _[88_ZB9<TO_ )_Q#+_ ,-_WD7-]N?[^']3])8W_P XL_\ */ZC_P Q
MY_Y-)GS4SW%XA].YL5=FQ5V;%79L5=FQ5V=<_P"<?_\ R:'DG_P)='_ZC(LY
MSVP_XS-3_P (R_\ 3.3L>R/\9Q?UX?[H,/\ S#_Y177?^V9>_P#)AL^K7_/S
MO_E ] _[;@_ZAI<^??\ @$_X_E_X5_OXO?\ MS_<0_K_ *"^2?\ G%G_ )2#
M4?\ F /_ "=3/B3GU*^7ON;-BKLV*NS8J[-BKLV*NS8J[/T)?E3_ .LQ0?\
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M\5N A%&$$:%A&3T$C,6 /PJC48=#[(_\!8:7(,_:,A,@V,<;,+Z<<B 9?U0
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MS](_XY?DW_F)U'_B$.>0?\ 3^]U/]7']\WK_ &\^G'[Y?H?/7_.*?^]6M?\
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M:-M4MK<6EHU*_6=4N%+-*0>JAN4A!Z1IP\,^0.SM/E]O>VS+)?!(\4OZ&"!
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MYL5=FQ5V;%79L5=GZ0/S3>31_P#G'[55T0$>EY0]*/B>'&,V@0D=:40DT]J
M]\^)NP ,_;^/Q.NIL]=^.Q\Y/M.O/!H)</\ J?V</ZGYH>4U6]_,2T-\:\]9
MYM7>K>L6'WMGYO\ /ME\6?I?FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=GU#
M_P"?7W_*4>:?^V;;_P#)[/!O^#S_ (K@_KR_W+W?L)_>S_JC[WRK_P Y4_\
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M(_QG%_7A_N@P_P#,/_E%==_[9E[_ ,F&SZM?\_._^4#T#_MN#_J&ESY]_P"
M3_C^7_A7^_B]_P"W/]Q#^O\ H+Y)_P"<6?\ E(-1_P"8 _\ )U,^).?4KY>^
MYLV*NS8J[-BKLV*NS8J[-BKL_0E^5/\ ZS%!_P" C?\ _)B7/CCV@_YR8_\
M0S#_ '47V'L__C-'_"Y?<7YT>;?_ ":<G_;8M_\ DXF?GMS['?'GZ+YL5=FQ
M5V;%79L5=GTO_P"?8<%NWGGS#=.?]*31>$8I^P]S&7W[;JFW?Z,\-_X.\Y#0
MX8CD<MGWB$J^\O;^PH'CS/7A_2/V/E__ )RFDD&@Z=$H_=-?<F-?VA$W';Y$
MX2_\_,;N[D_,S2K*XJ+6+0+=H!6H/.YN.;>Q)4*?91F5_P  S' =FY)#F<TK
M^$(4/MOXEK]N)$ZF(/+@%?.2._YQ>AA7RO=SQ[ROJ$@D--QQBCH/QK].?.K/
M:'C'TEFQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=GNW_G K\BO^5H^=QYTUR'
MGY=\LM'<N'%5FO":P1;]0I!E;J/A56%'SR;_ (+GM9_)&B_+XC63/<1WQQ_Q
MR^/T#WDCZ7J_9+LK\WF\20],-_?+^$?I/N\W@7_.0/G[_"FA'1+!^.I:H&B6
MAW2'_=C?37B/F2/LYVC_ )^1_G?^D;^S_(W093Z%B4OM6*G9IG6L$)I_(A]1
MAT)=.Z9S'_ 1]E?"QR[2RC>5PQ_U0?7/_.(X1_5ET+L_;7M3BD--'IO+W]!\
M!O\ $=S"/^<9O(OU:WF\^:@G[R?E;V8(Z(#^\<?ZS#B/]5NQSY59] / OK3/
MLQ_S[@_.Q=<T>\_([7Y.5UIH>\TSF:\[61OWT0K_ +[D;D!W60]DSYE_X-GL
MM^7S1[2Q#:=0R5TF!Z9?YT17OB.LGTKV+[4\2!TTN<=X_P!7J/@=_CY/BC_G
M)?R,;&]A\]Z>M(KHK!=<?V95'P/_ +)13YJ.[9X5_P"<Q?R-/Y(^?KFVTR(I
MY<UCE?Z80/A16;][!X5B<T W_=F,G<YZQ_P-?:O^7]!$S/[W'4,G>2/IG_GC
M<_TA+N>5]I.ROR&<B/TRWC^D? _93WO\E_/@\]>7HI;IZZG94M[H'J2!\,G^
MS&Y_R@WAGE'/0GGWKF;%79L5=FQ5V;%79+OR_P#^4HT3_MI6?_)Y<UW;'^*Y
M?ZD_]R7(T?\ >Q_K#[TG\Q?\<J^_YA9O^('/MM_S\B_\E-#_ -MRS_Y-39\M
M?\!+_C5/_"I_?!]0]M?\5']<?<7PS_SC-_RE[_\ ,!-_Q-,^#>?6SY.^_LV*
MNS8J[-BKLV*NS8J[-BKL?'(\+K+$Q5U(964T((Z$'QP2B)"BD&FF4."C@%2*
M$'H1GU%_(_\ Y^0:AY>M(/+GYTV,VK0PJ(UU6S*_6BHV'K1,520^+AD8@58.
MQ)/@GM5_P$\>IF<W9TAC)W\.5\'^;(68C^B1(=QB-GN^RO;66("&H!E_2'U?
M$<C[['Q?*?GO_G&BWU*:34O)$Z6CN2QM)J^E4]>#"I4?Y)##P(&V>FK[S3_S
MBU_SD>YN-?ET<:M<?;DN^>E7A<] 9CZ)D:O3XW!Z;[C.&Q=G^U'LN*Q#+P#I
M&L^.OZOKX1_FQ+O)ZCLSM3>7#9[_ $2^>U_,O+X-)_-?\M%]/3TO39Q]%AXW
M<-!X)\?$?[%3G.?.O_/M#RIK<)U+\KO,-U8M(O...\"7ENW@%>/TW53XGU#\
M\W79?_!RU6GEP:W#&5;$QO',>\2X@3Y>EPM5[$8L@O#,CW^H?,4?O9)H?_.4
M&KV+BU\UZ;%.%/%FA+0R#YJW($^WPY\U_P Z?^<=/._Y#726_GFR!L)G*6^H
MVK&6TF(%:!Z JU-^+JC$ D @5SV_V8]M-%[11O32]0WE"7IG'X6;'G$D>=O$
M]I]C9NSC60;'E(;Q/Q_0:+Z<\D?F3H7Y@1&309S]80<I+:4!9D'B5J01[J2/
M?.%YUCJF>YL5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79__]#\_P#BK]_,V*NS
M8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKQ[SI^0/Y?>
M?R\WF30+-[EP:W$*>A-4]R\?$D_ZU<V*OEWS3_S[[\LWO.;R=K-[ISD#A'<J
MES&#\_@?_ALV*OG[S#_S@?\ F!I19]!N=-U2("HXRO!(?]C(I7_DIFQ5X]K'
M_../YF^7R5U#ROJ#@?M6J+=#_D@TF;%7G=]Y;UC1F]/6-.O+1AL1/;RQ[_[)
M1FQ5 >HL>TA"GWVS8JC8Y$/1E^\8+AL+FX3U8(9'2I')4)%1U%0/?*Y9HQ-$
M@?%D($\@_2?_ )P-FCCT[S,9'50;NTH20*TB;!":+J,N\=I<-3K2)S_#('58
MQSD/F$C%(]#\GWTU];)]J:,?-Q_7!=OY5UJ[)2UTV\E8"I"6\C$#Z!E<^T,,
M/JG$>^0_6R&GF>0/R*C)JUC".4MS"H\6D4?QP[M/RP\X7X4V6@:I*'/%>%E,
M:GP%%S%R=O:/']67&/?./ZVV.AS2Y0E\B@9O-6BV]?7U&T2@J>4Z"@^_)';?
MD'^9%V.4/E36>.XY-93(NWBS* /OS!R>U_9L.>HQ?Z>)/R!;X]DZB7^3E\BE
M<WYA^6(-I-7L:^ G0G[@:X;P_P#.-GYBR;S:.ML/^7N\M+>GS]65:4[^&8\O
M;?LX<LG%_5A.?^YB6P=B:@_PU[S$?>0E\OYJ^5HNE^)/^,44LG_$$.&<?_.-
M7F1!75=1T2R'?U-06:G_ $C+-^&42]N-,?HAEE[L9C_TT,&8[$R?Q&(_SK_W
M/$E\GYO:(-K6*]G_ -2W*?\ )PI@@?D5I-B.6N>:[:HZC3[&YN#]'K"V'ZLA
M_HLRY/[K3R_SYPA_N/$9?R5"/U9!_F@G[^%+Y/S9:3;3]*F;P,\T<?\ Q R8
M&F\F_E_HX'KS:YJCCKP6VLE/_!?6#DX]I]H9^0Q0]_'D/V>&Q.FP0ZSE\H_\
M4A6\_P"O71/U>WLK8?Y;23'\/3&$ESYG\KZ(2=$\IVLC 4#ZE>7%R>G4I&84
M_#,K'H-5J/[S42'ECA"'VR$Y-4L^*'TXQ_G$G[N$*1U37+\4NM4>,'J+:&./
M[BP<Y=G^;_F*,@:";+1DI0#3+&WMW _XRA#+_P /CD]F].?[WBR?\,G*8_TM
M\'^Q6/:.0?34?ZL0/MJ_M2VZTF&YK^D)+B[KO_I$\CC_ (&H7_A<4DUO4M?F
M^NZ]>W-]<'K+=3/,_P#P3DG(QTN/31X<48Q'=$"(^0 2<LLAN1)]YO[T*EI!
M9)Z5G%'"G\L:A1]PIDJTWMFOSN3! 3]\Z!IO;-/G<N"4SY/]-[9J,[EP2F?.
M@:;VS3YW,@E,V=#TF-7Y/-(D%O$CS3SR&D<42#D\CGLJ@5.:742K8 DD@ #G
M*1V$1YDN9C'?MU)[AWI/-R)6.)6DE=@D:+NSNQHJ@>).?-O\_OS=;\U=>7]&
M%T\N:6K6^F1,*$J35YW'^_)B.1_E4(G[.>W>Q_LY_(^#UT<L_5D/GT@/Z,!L
M.\W+J\5VOVC^<R;?3':(^\GS/ZAT?6OY<^2U\GZ=QN>+:G=$273C< T^%%/\
MJ#8>)J>^<(SK74O0<V*NS8J[-BKLV*NS8J[-BKLEWY?_ /*4:)_VTK/_ )/+
MFN[8_P 5R_U)_P"Y+D:/^]C_ %A]Z3^8O^.5??\ ,+-_Q Y]MO\ GY%_Y*:'
M_MN6?_)J;/EK_@)?\:I_X5/[X/J'MK_BH_KC[B^&?^<9O^4O?_F F_XFF?!O
M/K9\G??V;%79L5=FQ5V;%79L5=FQ5V;%79ZX_P"<$_\ R>/E;_MY?]TVYSSK
M_@L_\8F?_DG_ --<;T7LI_CL/\[_ '$GCWY^?\H'JW_1K_U$Q9ZA_P"?I'_'
M4\F_\PVH_P#$X<X+_@"?W6I_K8_NF[WV\^K'[I?H>5?\XI_[RZU_QEMO^(OG
MRFSZ"> ?6V;%79L5=GZ$M;_]963_ ,U_:?\ =.3/CC2_\Y2?^AR7_34OL.7_
M (R_^2(_W ?G18_^39;_ ,"*;_J);/SVY]COCS]%\V*NS8J[-BKLV*NR9?E[
MY%U/\R_,FF^1/+:<]0U.X2".H/% =WD:G[**"['^4'-9VSVMB[*TT]5F-1A$
MD^?=$><C0'F7)T>DEJLD<4.<C7[?AS23S'KUKY7TRZU_4VXVUK&9&\2>RCW8
MT ]SGZ3=,L_)?Y!^3M,\D7FL67E_2;:W^I6UU>W5O:L\O$EY TQ"-*S%I&V(
MY$GC3;/B+/DUOM'K)ZF..6:<I<<HPC*=1O:-1]0@!41N-NMOMD(X>SL,<9D(
M "@21'?OWVOJ_,JZFUO\P=:NM=ALI]1O)9/7EB@BDE"I6BJ0E6" 44;].^>#
M)O\ G&+_ )Q:N)'N+CS_  22R,6=V\RZ<69B:DDD5))ZG/6X^W?M1$4-(0!R
M'Y?+^MY(]A=F'<Y1_P K(OH!/S2_->-1''Y>D5%   TNY  '0 5Q/_H5S_G%
M;_J?;;_PI-._YIR7^CWVI_Y1)?\ 7/E_6O\ (/9?^JC_ )607?\ *UOS9_ZE
M^7_N&7/]<ZC^4'Y>?\X\?DAY@7SMY'_,"Q6^]"2VDCG\Q:>\4L4@%5=1Q) 8
M*PW'Q*#[9H/:3MGVA[?T_P"6U.DGPV) C3Y1*)'4'?I8.W(ESNSM'V?H,GB8
M\HNJWR1H@]_WL4\Y>8_S'\]:<=#UWR[.8/4656CTVY5U9>ZDUIL2#MT)PP_Y
MSK_):W_.#R%'^8WE()=:QH,1O8)+<B075A(H:559:\P%I+&03L&"_;RG_@3^
MU$NQ->=)GN,,IX");<&4;1)!Y;W"7O%_2S]J^S!K<'BPWE#<5_%'K[^\?M0_
MY">=Y/)GF!O+6L%HK+4'$$BR57TKA31"0>E35&^8K]G/@MGUP^3/T!S8J[-B
MKLV*NS8J[.Y_\XR?^39\F?\ ;<LO^3HSE/;K_C*U/_"I_<7:]A_XUC_KC[V!
M_FC_ ,HAK?\ S 3_ /$#GTL_Y^@_\HOY7_[:5Q_R9SP[_@#?XUG_ *D?]T]O
M[=_W4/ZQ^Y\P_P#.*W_'5U7_ )A8_P#B>?'#2=5O-"O;?6M'G>VO[25)X)HF
MXO')&0RLI'0@BHSZ6U&GAJ(''D E&0((/(@[$'WOFV/(<<A*)HC<'S?:5W:0
MW\$EC>QK+;S(T<B,*JRL*$$>!&??S\E_S)\L?\YI?EG=^5//,,3ZLD*VNL6B
MT5DEI^[NX/Y0Q'-#^PX9#4"K?('M/V'J?83M*.?3$\%F6*70Q_BQS[Z!X9?S
MHD2VO;UWLS6XNW=,89.=5(>?20^\=QV?GGYW\L:I^2/FB'5M!=A:%S+93&I#
M)^U"_B0#Q;Q4AMJ[?%'\\/R;UG\C/-=WY&\Q@NJ?O;.Z"E4N;9B>$J]? AA4
M\7#+4TKGU%[*^TV'VATL=3AVO:4>L)CG$_>#UB07S#M7LV?9^4XY_ _SAT/X
MZON+R)YULO/ND0Z]IAXEO@FBK5HI0/B0_K![@@YR'.C=<S+-BKLV*NS8J[-B
MKL]%?\XD_P#DX?)__;23_B#9Q?\ P1/^,C4?U#]X=S[/?XWC_K/-OS@_Y0S6
M?^84_K&>_O\ GZ1_QR_)O_,3J/\ Q"'/(/\ @"?WNI_JX_OF]?[>?3C]\OT/
MGK_G%/\ WJUK_C%;?\2?/D_Y*\WZEY U[3O.OER3TM2TRYCN8&->)9#7BP%*
MJPJK#NI([Y]"=J=FX^TL$]/F%QG$Q/QZCS','H=WS[2ZF6FR#)#G$V'USKFC
M6WF'3[G0]27E;7431..]&'4>!'4'L<^\'YT>5-,_YS$_)6#S-Y/4/J9MQJNE
M@49TNHE*S6I.V[$/">W,*VX49\E>S':&7V([:.'4;1XO#R=QA(@QR>X>F??P
MV.KZQVGIX]MZ,3Q\ZXH_UASC]\??N^ O)&K77Y,>>)-+UDE;42&TNST4Q.04
ME'L/A<=^-1WSR3_S[A_(MM0U.]_.WS'!^XTYI+#2DD4U-R12>6A_WVA]-3_,
M[]&3/1?^#9[5^%BCV;A.\ZGDK^9_!'_.(XCY1CTD\][%]E<4CJ9CEM'W]3\!
MM\3W/8/^<E_/HMK6#R-ILG[RY"W%V5/^Z@?@3_9$<C[*O9LX=_SGA^> _-7S
MX_EC19N?E[RT9+.'BU4ENJTN)138CD!&IW^%.0^WG5?\"7V5_D?0#-D%9,U3
M/?&'\$?D>(^<J/)U7M9VI^<S\$?IAL/.7\1_1\/-GGY ^1/\)>7UU6^3CJ.J
M<9WJ-TBI^[3[CR/NU#TSE'_.)/\ Y.'R?_VTD_X@V=#_ ,$3_C(U']0_>'7^
MSW^-X_ZS+?S@_P"4,UG_ )A3^L9[^_Y^D?\ '+\F_P#,3J/_ !"'/(/^ )_>
MZG^KC^^;U_MY]./WR_0^>O\ G%/_ 'JUK_C%;?\ $GSX[Y])OF[[.S8J[-BK
MLV*NS8J[/=W_ #@5^17_ "M'SN/.NN1!_+OEEH[EPXJLUX=X(_<*09&Z_956
M%'SR;_@N>UG\D:+\OB/[S/<1WQQ_QR^/TCWDCZ7J_9+LK\WF\27TPW]\N@_2
M?VO O^<@?/W^%-".AV#TU+5 T0(.Z0C:1OF:\1\R1]G/JU^?_P#RJO\ ,33I
M/RM_-3SA8Z.L4\-Q<V:ZO:6=PQ5>4:RK*2W'X@X%!4A6[#/GSV/_ )4[,R#6
MZ'3SR6#&,O"GDCN:D8F.U[&-WWA] [7_ "NICX.?(([@D<<8GRN_G\GR3^7G
M^+/+=ROFORGHT]Z6C>.*8V<TT8!-&*%*"NQ6M?$9X_\ ^A7/^<5O^I]MO_"D
MT[_FG/2?]'OM3_RB2_ZY\OZWG/Y![+_U4?\ *R#V7_E:WYL_]2_+_P!PRY_K
MF_Z%<_YQ6_ZGVV_\*33O^:<?]'OM3_RB2_ZY\OZU_D'LO_51_P K(._Y6M^;
M/_4OR_\ <,N?ZYZY_P"<?U_*C\M;!/RP_*OSE8ZNMS<RW%M9/K%G=SAV2LBP
MK$0W&B%RH!I\3=SGG/M@>U>U<GYW6Z:>/AB(RGX63'&K])D96+WX0;[AW/0]
MD?E=+'P<&02LD@<<9'SJO=;QW\PSYN\SW!\U>;-%N+,Q1)').+*:&.@:BER]
M16IX@U\!X9\P/^?@7Y%'\NO.(_,C0H>&@^9I'ED"CX8K_P"U,I\/5_O1XL9
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M9E[_ ,F&SZM?\_._^4#T#_MN#_J&ESY]_P" 3_C^7_A7^_B]_P"W/]Q#^O\
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M *E?JL,9-3ZI(*N3[CD?V0.WQ(U"2VENIY=,C>&S:5S!%+()'2,L>*LX5 S
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M*_E'RO:Z%KMT\5Y$\S,JPR. 'D+#=01T.>:O^A ?SI_ZLUM_W$+7_JIG<?\
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M0CC3_5Y'VSZ,?\Y"?G'Y5_YQ5_+>/\K/)\ROYA_1OZ.TNS#AY8D9.!NIZ?9
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M,O\ U4>@_P!%>M_G_P"QA_Q+R3_E0?D/_JT_]/5S_P!5<W_0]GYX_P#4T_\
M<MTW_LFQ_P"33=B?ZA_TLR_]5%_T5ZW^?_L8?\2[_E0?D/\ ZM/_ $]7/_57
M-_T/9^>/_4T_]RW3?^R;'_DTW8G^H?\ 2S+_ -5%_P!%>M_G_P"QA_Q+O^5!
M^0_^K3_T]7/_ %5R.^;?^<P/S<\]:/>>4/-7F+ZUI-_$8;F#ZA8Q\T)K3E'
MKCIU5@<S>SO^!OV3V?FCJ,&'AG W$\>0T?=*9!^(:-1[1ZO40..<[!V(X8_H
M%IEH_P"37D[0+V'6-)TWTKRW;G$_UBX;BWC1I"#](SS3G<.D>GYL5=FQ5V;%
M79L5=G??RS_YR?\ S,_*6*/3_)^O3KID6RV-T%N;<+_*J2AO3'_&,IG(=N^P
M?9O;),]1B'$?XXW"?O)C7%_G6[?0]NZG1BL<S7<=Q]O+X4\]\T?E7Y7\WNUS
MK.GQFZ;K/%6*0GQ+)3D?]:N>D;?_ )^7_FG!&L4NF^79F'5WM+H,?GQNE'W
M9Q$_^ ;V7(V)YAY"4/TXR?M=U'VWU0_AA\I?\4\SD_YQ?\J.Q=;G4D!_96:*
M@^^(G\<@7G7_ )S[_-_SC"UG:ZA:Z)"X(8:5;>FQ!\))6ED7YJZGWS;]E_\
M A[(T)XI0EE(_P!4E8_TL1")^(+B:KVNU><4"(_U17VFS\BR#0_^<>_)NBN)
MI;:6^==P;N3D/I5 BGZ0<\=:AJ-WJ]S+J>JSRW5Y.YDEFG=I)'8]69F)))[D
MG/2L.&&&(A ",1L !0 [@!L'FYS,SQ2-D]3S>T6UM#9Q):VD:10Q@*B(H55
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MO_\ )0-_VV;W_B$6?)7_  9O^-?_ ))0^^3ZQ[&_XI_G']#X!_YR1_Y3(?\
M,%!^ML]9:MWSSS3O0Y'C%OG,M5[YO=.X.1/K;.8ZKWS?:=P,B?6W;.9:MWS>
MZ=P<B?09S+5N^;W3N#D3ZWZYS+5N^;W3N#D3^V[9S'5N^;W3N!D3VVSF>K]\
MWNF<+(GUMG,=6[YO=.X$T^MN@P%IW;+<[&"K-WSH>DQO,Z0PJSR.0JJH)9B>
M@ &Y)\,TVHD(@D[ .9C%[)1<,%!=B H!))V SL%Y:Z1^7$8N?S)E8:@!RCT.
MT=?KC'M]8?=;93X,&EI_NL=<YK'DR]J&M&/3US2!\,?\+&QRGW5#^D[*0AI=
M\W/^8/J_SOYOW^2"TK2M0\UM30D"6=:->S ^E3_BM=C(?<43_*SA/G_\T=7\
M_M':7?"ST6V8FTTRUJMM#7;E0DEY"/M2.6=O&E .M['[!P]F@RC<IR^K)+><
MO+^C'NC&HCNO=U.KU\]3L=HCE$<A^L^9W>T^6?)]AY71FM 9;R0 374M#+)[
M5[*.RBBCY[YS?-VX3*\V*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-
MBKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*
MNS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[
M-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV
M*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J
M[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKL
MV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8
MJ[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BK
MLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS
M8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-B
MKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[/_U?S_ .*OW\S8J[-B
MKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*N
MS8J[-BKLV*NS[P?\^[__ "4#?]MF]_XA%GR5_P &;_C7_P"24/OD^L>QO^*?
MYQ_0^ ?^<D?^4R'_ #!0?K;/66K=\\\T[T.1XQ;YS+5>^;W3N#D3ZVSF.J]\
MWVG<#(GUMVSF6K=\WNG<'(GT&<RU;OF]T[@Y$^M^N<RU;OF]T[@Y$_MNV<QU
M;OF]T[@9$]MLYGJ_?-[IG"R)];9S34HWG<6\"EY7-%102Q)[ #<YO,$A$6=@
M.K@S%[!/8&"+S<@*.I.P&="L/RS;R[$M_P#FA?1^7H"%=;1U];4Y5/3A: AH
MZCHTYB7PY9ILW;OYH\.BB<Q_G \.&/OR\I>[&)GW.9#1>%OF/!Y<YG_-Z?YU
M(>"YN-;;T?+5NU[U!GKPME(\92*-\D#'Y8Z__-V/0HFTS\J;-M&1E*2:E,XF
MU*4$4-)J 0 ^$ 5J;&1A@Q>SAU!X]=+Q.HQ@<.&/^;SR>_(2.HB%EVCX8K".
M'^ESF?C_  _YM>]F.E?ES"S+=^:I1?R@U6 +QMD/^IOS^;U'@HSB<DC2L996
M+.Q)9F-22>Y.=2  *#JR;>F*H0!4 "C8 =!C,*MYL5=FQ5V;%79L5=FQ5V;%
M79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=
MFQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;
M%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5
M=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V
M;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L
M5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5
MV;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79
ML5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ
M5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%7
M9L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=F
MQ5V;%79__];\_P#BK]_,V*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[
M-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKL^\'_/N__P E W_;9O?^(19\
ME?\ !F_XU_\ DE#[Y/K'L;_BG^<?T/@'_G)'_E,A_P P4'ZVSUEJW?//-.]#
MD>,6^<RU7OF]T[@Y$^MLYCJO?-]IW R)];=LYEJW?-[IW!R)]!G,M6[YO=.X
M.1/K?KG,=6(KQ[GH.YS>Z=P<B?VWCVR.77DO5[JW.ISP+9:?WN[^6.T@_P"1
MD[(I/L"2>P.9N/M3#"7 #Q2_FP!R2_TL 3\3LT2TTR+(H=Y(B/F:3*UO8GD%
MK;<KBX/^ZH$:5_\ @4!/WYRO5]0\BZ+7]+:K/K=T/^/;1XS%!7P:ZN%!_P"1
M<+ ]GSH--AUV?Z,8Q#^=E/%+X8X$_P"RR#SBZ_)/!C^J1D>Z.P_TTOT1^+/]
M,\I^8-0H1;QV$)_;NF#R?1%&2/\ @G'RR$77YR:A8*]KY L[;RW PH9;(%KU
MA2GQ7<E903W],Q@^&;7'[,X\AXM5*68]T]L8]V*-0_TW$?-Q9=I2CMB A[OJ
M_P!,=_E3/+#\N-.B*RZT\FI2C>EQ3T@?:):)_P $&^><AEE>=VFF8O(Y+,S&
MI).Y))ZDYT<8B(H<G7DVS]$5%"( % H -@ ,9A0NS8J[-BKLV*NS8J[-BKLV
M*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J
M[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKL
MV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8
MJ[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BK
MLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS
M8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-B
MKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*N
MS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-
MBKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*
MNS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[
M-BKLV*NS8J[-BKL__]?\_P#BK]_,V*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BK
MLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKL^\'_/N__P E W_;
M9O?^(19\E?\ !F_XU_\ DE#[Y/K'L;_BG^<?T/@'_G)'_E,A_P P4'ZVSUEJ
MW?//-.]#D>,6^<RU7OF]T[@Y$^MLYMJL3")[N0K';)]N:5ECC7YNQ"C[\WFG
MEOPC<]PW)^ W<'(-KZ=_3YI]: R.L$09Y3T1 68_("ISS)YN_.O\N_+Y:/4/
M,$=W..L.E0M>-_R,JD'_ "5SNNSO9?M#4[PPF([\A&,?Z7U9/]@Z/4]J:?'S
MG?E$<7V[1^UZKH_Y:^9]4 >'3S;QG]N[<0C_ ('XG_X3/._F#_G*/R\I9?+?
MEZYNV!VDU*[X(?G#;J"/^1QSL]'[!:@_WV:,?+'"S_IIDC_8!TV;M['_  0)
M_K']$?\ BGINF?DG>&C:MJ21@]4M8:D?[.0D?\)G)-7_ .<DO.-[6/1&L]%B
M)) TZU2.0?\ /5^<OT\\Z/3>Q&CQ[Y.+(?Z<B1_I14?L==D[:S2^FH_U17V\
M_M9YI_Y3^7[.C74<MZX'6YE9A_P HOX9Q;6-=U+S#.;_ %^\N+ZY.QEN97E?
M_@G).=/IM)CTT>'%&,1W1 B/D'69,LLAN1)/F;>@65A:Z;']7T^&."(?L1($
M7[@ ,*LR&M%YL5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=F
MQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%
M79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=
MFQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;
M%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5
M=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V
M;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L
M5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5
MV;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79
ML5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ
M5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V?_0
M_/\ XJ_?S-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*N
MS8J[-BKLV*NS8J[-BKLV*NS8J[/O!_S[O_\ )0-_VV;W_B$6?)7_  9O^-?_
M ))0^^3ZQ[&_XI_G']#X!_YR1_Y3(?\ ,%!^ML]5^8+J"P@FOK^6."VA0R2R
MRN$1$7JS,U  /$YY_H\<LDA&())-  62>X <W?YI"(L[ /'+""2YE2VMD:26
M1@J(@+,Q/0 #<G/E_P#G5_SG'INF22Z%^4%NFHW2DJVJW:'ZNI&W[B$T,GL\
ME%\(V!KGO'LO_P "K)E RZ\F _U.)]9_KS_A_JQW_I#D\+VG[51AZ< L_P X
M\O@.OO.WD^J_(OY 7%TJ:CYUD-O$0"+.$_O"/^+''V?DN_\ E#IGSM\Z_F7Y
MH_,2X^N^=-5N;]J_"DCGTD]DC%$4?ZH&>T=E]AZ7LR/#I\<8>8&Y]\N9^)>,
MU6MRZDWDD3]WRY/IC0O*^D^6HOJ^AVD5NO<HOQ-\V.Y^DY!LVKBI]FQ5V;%7
M9L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=F
MQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%
M79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=
MFQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;
M%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5
M=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V
M;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L
M5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5
MV;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79
ML5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ
M5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=FQ5V;%79L5=G__T?S_
M .*OW\S8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*
MNS8J[-BKLV*NS8J[-BKLV*NS[P_\^[A7\H2!U_3-[_Q&+/DK_@S_ /&O_P D
MH??)]8]C?\4_SC^A\ _\Y([><A_S!0?K;/!__.:'_.2\_P"9>M3_ )<^3KEE
M\I:9,8YFC-!?7$9H7)'6)"*1CH?M]UIZU_P,?8:/96$:O41_?3%B_P#)P/3R
MD1]1YCZ>^^3]INW#JIG%C/HCS_I$=?<.GS>_?DA^5T?E:QC\RZU$#K%T@9 P
MW@C8;*/!B/M'J/L^-?!V>MO)OH#-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[
M-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV
M*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J
M[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKL
MV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8
MJ[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BK
MLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS
M8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-B
MKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*N
MS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-
MBKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*
MNS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS_TOS_ .*OW\S8J[-BKLV*NS8J
M[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKL
MV*NSZC?E3^:4GY4_\XK:KJNG2>GJNH:Q>:;9L#1E>=(PSCW6,,0>QIG@GM!V
M .V/:G'"8N$,4,DO=$RH?&5#W/>=GZ_\GV7*0YF1B/C7Z+?*?FWRHOFW\V;2
MTN5Y6EO90W,P/0K&S$ _-J#/ER37<Y[V\&^K,V*NS8J[-BKLV*NS8J[-BKLV
M*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J
M[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKL
MV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8
MJ[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BK
MLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS
M8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-B
MKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*N
MS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-
MBKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*
MNS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[
M-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKL_]/\_P#BK]_,
MV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8
MJ[-BKLV*NS8J[-BKL[3YA\\PW/Y8^6_R[LY@TEKJNJ:A=Q"M5:184A)[&JA\
MY?1]E2AVGFU<AM+'BA$]X!D9_;PNSS:H'30Q \I2D?C0'Z6$:=H+Q>:=3\R3
M(0LMI:6T+^(4NSC[^.<6SJ'6,WS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS
M8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-B
MKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*N
MS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-
MBKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*
MNS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[
M-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV
M*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J
M[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKL
MV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8
MJ[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BK
MLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS__U/S_ .*OW\S8J[-BKLV*
MNS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[
M-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV
M*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J
M[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKL
MV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8
MJ[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BK
MLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS
M8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-B
MKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*N
MS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-
MBKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*
MNS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[
M-BKLV*NS8J[-BKLV*NS8J[-BKL__U?S_ .*OW\S8J[-BKLV*NS8J[-BKLV*N
MS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-
MBKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*
MNS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[
M-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV
M*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J
M[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKL
MV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8
MJ[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BK
MLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS
M8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-B
MKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*N
MS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-BKLV*NS8J[-
-BKLV*NS8J[-BKL__V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
